data_5jpl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jpl _Structure_validation_residue.Date_analyzed 2017-03-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.232 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.493 ' HE ' HD22 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.75 151.34 39.89 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 117.082 0.441 . . . . 0.0 111.024 -178.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.06 111.43 2.44 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.15 2.567 . . . . 0.0 112.363 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.493 HD22 ' HE ' ' A' ' 2' ' ' ARG . 4.9 p30 175.62 21.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.727 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.7 t90 41.63 69.69 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.958 0.409 . . . . 0.0 110.13 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.67 -85.87 1.89 Allowed Glycine 0 N--CA 1.463 0.449 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.948 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.75 -41.84 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.705 0.252 . . . . 0.0 111.409 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.599 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.0 pt-20 -67.53 148.37 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.508 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 11' ' ' TRP . 0.6 OUTLIER 40.07 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 50.83 22.84 1.24 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.721 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.681 ' N ' HD21 ' A' ' 9' ' ' ASN . 80.3 m95 -144.02 7.16 1.39 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 110.401 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.609 ' N ' HD22 ' A' ' 9' ' ' ASN . 2.3 m -159.36 166.42 31.17 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.918 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -104.55 154.02 20.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 111.057 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 15' ' ' ARG . 35.2 m -76.88 -54.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 17' ' ' CYS . 67.2 ttt180 -173.16 163.53 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 17' ' ' CYS . 92.0 t 55.45 -86.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' ARG . 12.0 m . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' ASN . 37.0 mtp85 -129.23 93.75 35.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.893 -0.181 . . . . 0.0 111.167 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.36 83.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.657 2.238 . . . . 0.0 112.915 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' ARG . 14.1 t-20 -172.69 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.748 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 10.0 m0 53.55 107.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.96 -130.34 1.18 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' SER . 78.2 m-85 -88.71 -65.62 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 2.5 pt-20 -48.66 147.66 2.46 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.435 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.738 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.82 17.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.922 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.4 t0 48.87 11.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.413 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.738 ' H ' HD21 ' A' ' 9' ' ' ASN . 83.6 m95 -133.57 15.31 4.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.601 ' N ' HD22 ' A' ' 9' ' ' ASN . 3.9 m -162.23 162.2 28.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.388 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.51 155.05 18.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.785 0.326 . . . . 0.0 110.311 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -94.38 -162.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.338 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -55.07 -43.48 73.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.688 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.3 108.46 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 110.465 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 36.5 t . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.435 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -38.71 102.04 0.24 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.986 -0.107 . . . . 0.0 111.132 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.41 100.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.075 1.85 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' TRP . 45.4 t-20 -172.89 23.92 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.602 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.495 ' HE1' ' HE1' ' A' ' 11' ' ' TRP . 5.3 m-90 51.5 104.22 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.445 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -158.78 -148.85 5.32 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.21 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.1 -56.45 6.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -58.09 148.81 25.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.385 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 42.06 16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.9 m-20 47.06 22.85 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.685 ' N ' HD21 ' A' ' 9' ' ' ASN . 82.6 t90 -144.5 10.38 1.43 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.668 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.7 ' N ' HD22 ' A' ' 9' ' ' ASN . 4.3 m -162.73 162.96 27.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 2' ' ' ARG . 5.0 m -91.75 158.17 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.72 0.295 . . . . 0.0 111.02 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 m -78.75 -37.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.53 -72.06 0.32 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 m -122.25 131.42 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.143 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.488 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.262 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -174.94 104.09 0.26 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.956 0.378 . . . . 0.0 111.415 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.53 86.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.294 1.996 . . . . 0.0 112.658 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.6 m-20 -159.62 28.58 0.19 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 84.3 t90 47.63 91.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.42 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -143.13 -143.98 4.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -76.73 -57.83 3.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -54.64 143.59 24.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.224 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.776 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.8 OUTLIER 41.8 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.638 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 8' ' ' GLU . 42.3 t0 54.46 -0.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.655 0.264 . . . . 0.0 110.96 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.776 ' H ' HD21 ' A' ' 9' ' ' ASN . 3.3 m0 -112.88 0.4 15.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.803 0.335 . . . . 0.0 110.478 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.553 ' N ' HD22 ' A' ' 9' ' ' ASN . 4.2 p -159.29 166.81 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.222 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 10.6 t -99.22 163.39 12.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 32.8 m -90.97 -156.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -83.05 -47.63 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' CYS . 86.2 t -63.83 -46.79 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.349 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 14' ' ' VAL . 85.0 m . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.036 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.804 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.626 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -54.31 151.05 14.39 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.49 -178.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.98 99.85 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.674 2.249 . . . . 0.0 112.493 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 5' ' ' TRP . 14.7 t30 -174.98 -128.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.396 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.675 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 52.7 p-90 -161.48 99.72 1.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . . . -141.15 -156.83 6.95 Favored Glycine 0 N--CA 1.466 0.633 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.65 -38.5 89.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.006 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -70.29 145.03 51.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.53 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.54 ' ND2' ' CB ' ' A' ' 11' ' ' TRP . 5.4 t30 46.7 12.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 110.782 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' GLU . 6.0 p-10 43.07 19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.54 ' CB ' ' ND2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.79 19.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.629 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' GLY . 3.6 m -147.13 150.15 34.41 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 110.258 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' ' ND2' ' A' ' 4' ' ' ASN . 1.1 m -63.51 151.71 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.27 -45.59 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.429 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -140.77 -84.87 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.973 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.19 9.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.495 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.702 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -132.08 92.4 29.46 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.26 85.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.305 2.003 . . . . 0.0 112.898 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.2 m-20 -160.55 32.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 54.26 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.547 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -155.28 -139.21 2.73 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.4 m-85 -80.35 -79.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -48.33 161.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.756 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' A' ' 11' ' ' TRP . 25.9 t30 55.61 7.66 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 109.997 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.9 m-20 57.83 9.9 0.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.43 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 4.4 m-90 -160.16 29.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.547 ' N ' ' H ' ' A' ' 6' ' ' GLY . 67.1 m -153.29 147.88 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 14' ' ' VAL . 1.2 t -71.72 164.35 26.12 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -92.2 -165.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -55.45 -43.1 75.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 110.472 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.33 131.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.609 179.743 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.496 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.6 ptm85 -170.2 153.92 4.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.558 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.87 167.01 2.51 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.74 2.294 . . . . 0.0 112.142 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 37.1 t30 76.1 155.58 0.17 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.123 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 12.3 m0 -74.13 132.09 41.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.34 -137.21 2.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' SER . 94.7 m-85 -87.07 -83.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.679 0.276 . . . . 0.0 111.662 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.6 pt-20 -44.02 159.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.855 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 11' ' ' TRP . 20.4 t30 53.88 12.2 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.129 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 68.8 m-20 57.57 7.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.114 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 5.0 m-90 -159.34 35.65 0.2 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.49 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 7' ' ' PHE . 38.7 m -158.52 140.78 14.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.1 m -68.87 158.31 34.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.032 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.55 -143.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.397 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -59.32 -43.31 92.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.13 124.87 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.315 179.721 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.424 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.509 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -82.35 156.36 68.8 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.847 0.356 . . . . 0.0 111.058 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 34.3 Cg_endo -62.07 169.68 7.28 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.604 2.203 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 83.36 114.4 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.209 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 42.2 p90 -37.82 120.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.07 -142.69 3.69 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.2 m-85 -80.82 -73.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -49.41 152.78 1.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.812 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 11' ' ' TRP . 8.2 t30 54.24 8.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.214 0.531 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 55.75 5.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.942 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.557 ' H ' ' C ' ' A' ' 9' ' ' ASN . 2.7 t-105 -142.66 21.23 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.17 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 13' ' ' CYS . 2.1 t -154.35 153.53 31.77 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.312 0.577 . . . . 0.0 110.388 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.689 ' N ' ' HG ' ' A' ' 12' ' ' SER . 5.9 m -83.74 159.94 21.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.394 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -80.4 -39.1 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -145.03 -65.07 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.37 131.3 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.627 -179.783 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' PRO . 16.0 mtp85 -82.45 141.39 45.49 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' ARG . 76.6 Cg_exo -41.12 172.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.721 2.281 . . . . 0.0 112.454 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' PRO . 76.9 m-20 58.3 121.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.816 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -41.15 135.31 1.88 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.88 -139.22 3.03 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -85.19 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 111.097 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' ASP . 7.2 pt-20 -50.32 145.93 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.732 HD21 ' N ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 40.98 17.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.284 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.3 t0 46.25 15.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.732 ' N ' HD21 ' A' ' 9' ' ' ASN . 69.2 t90 -135.83 12.28 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.702 ' N ' HD22 ' A' ' 9' ' ' ASN . 2.5 m -164.22 166.23 21.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.259 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 8' ' ' GLU . 7.8 m -98.03 149.72 22.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.96 -23.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.037 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -167.68 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.84 133.99 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.769 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.704 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.62 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -72.79 154.36 91.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 0.0 110.702 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.29 -22.44 60.42 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.96 2.44 . . . . 0.0 112.519 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 5' ' ' TRP . 98.4 m-20 -68.7 118.97 12.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 4' ' ' ASN . 62.5 p-90 -32.89 141.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.598 0.561 . . . . 0.0 111.227 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.75 -135.37 2.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.292 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' SER . 89.9 m-85 -86.4 -62.49 1.5 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' C ' ' N ' ' A' ' 10' ' ' ASP . 4.2 pt-20 -50.98 162.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.227 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' TRP . 12.8 t30 46.38 18.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.539 0.685 . . . . 0.0 110.144 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 8' ' ' GLU . 24.4 t0 51.45 11.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' ASN . 59.2 t-105 -159.45 37.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -167.48 151.04 6.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -81.05 158.98 24.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -98.28 -168.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.955 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -52.02 -44.32 64.12 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.314 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.65 122.94 56.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.468 -179.892 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.622 ' H ' ' CB ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.678 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.73 148.01 64.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 122.968 -0.136 . . . . 0.0 110.775 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 2' ' ' ARG . 50.8 Cg_exo -40.55 179.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.747 2.298 . . . . 0.0 112.468 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 4.4 m-20 79.2 98.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASN . 42.5 p-90 -35.53 121.94 0.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.21 -130.75 2.53 Favored Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -93.64 -68.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.56 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 6.7 pt-20 -46.26 145.08 1.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.748 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.31 18.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.867 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 45.84 13.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.946 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.748 ' H ' HD21 ' A' ' 9' ' ' ASN . 78.6 m95 -133.53 11.11 4.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.727 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.698 ' N ' HD22 ' A' ' 9' ' ' ASN . 3.7 m -159.95 162.76 34.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.911 0.386 . . . . 0.0 110.849 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.642 ' CB ' ' HE ' ' A' ' 2' ' ' ARG . 5.6 m -89.58 159.73 17.03 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 121.371 0.605 . . . . 0.0 111.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -97.26 -118.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.456 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -67.55 -55.9 11.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.302 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.97 164.92 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.432 179.496 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.467 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -89.61 159.1 44.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 2' ' ' ARG . 13.7 Cg_endo -54.2 -162.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.839 2.359 . . . . 0.0 112.085 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.41 113.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 66.6 p-90 -40.16 125.49 2.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.842 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.3 -136.71 2.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.3 m-85 -90.97 -70.8 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 10' ' ' ASP . 5.6 pt-20 -49.67 150.92 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.55 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' TRP . 9.9 t30 55.57 6.2 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.023 0.44 . . . . 0.0 110.315 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 8' ' ' GLU . 20.7 t70 63.09 2.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.353 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' ASN . 5.7 t90 -146.86 26.85 1.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.708 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.9 m -153.97 147.27 24.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -80.36 165.75 21.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.102 -179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.39 -172.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.187 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.43 140.73 58.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.269 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 t 67.82 59.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.201 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.483 -179.609 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.474 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 4.5 ptm180 -173.36 154.4 2.53 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 26.3 Cg_endo -59.78 156.27 38.85 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.509 2.139 . . . . 0.0 112.228 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 90.13 110.21 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.329 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -40.53 114.53 0.47 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -138.43 -142.03 4.25 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' SER . 96.8 m-85 -80.69 -64.65 1.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.6 pt-20 -57.03 147.55 23.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.003 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 11' ' ' TRP . 5.8 t30 56.33 5.22 0.17 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 8' ' ' GLU . 48.6 t0 62.19 -0.12 0.52 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.528 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -134.47 20.74 3.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 7' ' ' PHE . 5.7 p -156.58 155.25 31.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 1.6 m -86.9 152.3 22.56 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -77.06 -92.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.814 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' H ' HG23 ' A' ' 14' ' ' VAL . 78.7 ttt-85 -131.21 -21.93 2.57 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 53.4 t -121.67 131.92 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 1.7 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.168 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.637 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.71 146.96 65.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.775 -0.25 . . . . 0.0 111.658 -178.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.75 110.46 0.97 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.685 2.257 . . . . 0.0 112.329 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 56.5 t-20 -173.72 17.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 42.37 56.72 3.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.004 0.431 . . . . 0.0 110.405 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -85.6 -91.85 0.85 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.674 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' SER . 90.0 m-85 -154.1 -19.25 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 10' ' ' ASP . 1.4 pt-20 -59.1 -103.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.277 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.75 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -70.18 38.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 8' ' ' GLU . 5.8 p-10 43.79 21.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 110.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.75 ' H ' HD21 ' A' ' 9' ' ' ASN . 76.8 t90 -152.06 8.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.707 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.544 ' N ' HD22 ' A' ' 9' ' ' ASN . 2.5 m -158.13 176.22 12.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 1' ' ' GLY . 47.9 t -105.95 160.64 15.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.056 0.455 . . . . 0.0 110.9 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 m -81.6 -174.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.695 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -59.26 -45.62 90.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.95 107.33 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.845 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.2 m . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.609 -179.534 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.497 ' NH2' ' O ' ' A' ' 15' ' ' ARG . 8.3 mtp180 -128.92 145.68 57.47 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.38 84.99 0.9 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.77 2.313 . . . . 0.0 112.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 64.0 t30 -174.41 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.269 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.406 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 15.0 t90 -175.64 102.53 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.804 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -138.44 -48.56 0.06 OUTLIER Glycine 0 N--CA 1.466 0.646 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.598 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 94.5 m-85 -159.68 -60.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.573 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -52.87 148.13 8.06 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.789 -177.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.593 HD22 ' CB ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 53.61 8.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.869 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 53.42 21.7 2.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.593 ' CB ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -157.42 9.96 0.19 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.53 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -142.12 161.16 38.7 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.27 147.15 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.874 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.94 151.77 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.49 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.497 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 15.4 tpp180 42.94 -129.26 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' H ' ' CG ' ' A' ' 15' ' ' ARG . 96.7 t -63.95 -46.29 94.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.819 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.503 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.537 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -111.2 146.65 34.98 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.853 0.327 . . . . 0.0 111.5 -178.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 70.2 Cg_endo -71.26 86.96 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.677 2.252 . . . . 0.0 111.723 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 3' ' ' PRO . 17.7 m120 -155.5 25.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' ASN . 88.4 t90 47.57 98.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.463 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -150.46 -141.94 3.46 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.263 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.0 m-85 -81.27 -54.22 5.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.4 pt-20 -68.19 151.92 46.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.65 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 11' ' ' TRP . 4.8 t30 55.03 6.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.114 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 8' ' ' GLU . 99.0 m-20 57.88 2.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.556 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 t-105 -139.47 20.85 2.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 2' ' ' ARG . 11.2 t -153.8 158.62 41.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.414 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' N ' ' HG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -95.96 155.59 16.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 15' ' ' ARG . 9.8 m -65.97 -44.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.09 0.472 . . . . 0.0 110.15 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.483 ' O ' ' CZ ' ' A' ' 2' ' ' ARG . 26.5 tpt85 -157.48 -38.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.715 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.68 131.7 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -79.7 158.71 72.89 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.956 0.408 . . . . 0.0 110.782 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.88 -20.92 58.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.602 2.201 . . . . 0.0 111.526 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 12' ' ' SER . 28.6 m120 -64.59 -169.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 16.3 p90 -107.04 141.05 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.869 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.484 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.71 -123.36 0.77 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.2 m-85 -99.23 -67.56 0.84 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -53.84 176.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.668 ' ND2' ' CD1' ' A' ' 11' ' ' TRP . 34.6 t30 48.43 16.2 0.1 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLU . 57.2 m-20 69.56 -10.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.052 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.668 ' CD1' ' ND2' ' A' ' 9' ' ' ASN . 1.2 p90 -166.43 73.14 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.529 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 7' ' ' PHE . 18.8 m -171.28 144.87 2.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.16 159.05 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 29.1 m -81.87 -160.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.813 0.339 . . . . 0.0 110.473 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.26 130.38 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.453 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.583 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -101.83 103.94 32.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 122.592 -0.358 . . . . 0.0 110.883 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.06 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.091 1.861 . . . . 0.0 112.188 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -173.0 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.838 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 44.02 88.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.317 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.98 -125.4 2.53 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.3 m-85 -94.33 -66.2 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.559 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 3.5 pt-20 -51.89 146.05 8.92 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.214 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.699 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 43.14 15.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.854 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.1 m-20 46.65 14.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.181 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.699 ' H ' HD21 ' A' ' 9' ' ' ASN . 13.3 t-105 -126.71 2.73 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.969 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.694 ' HG ' HD22 ' A' ' 9' ' ' ASN . 10.2 p -159.7 165.53 32.4 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.984 0.421 . . . . 0.0 111.444 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.5 t -90.2 160.93 15.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.769 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -71.08 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' VAL . 42.0 ttp85 -139.32 119.67 13.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 15' ' ' ARG . 35.3 t 53.53 107.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.9 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.526 179.801 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 4' ' ' ASN . 3.3 mtp85 -60.65 146.09 86.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 120.436 0.16 . . . . 0.0 111.011 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.12 25.46 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.897 2.398 . . . . 0.0 113.01 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' TRP . 13.9 m120 -126.48 120.38 29.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 121.44 -0.104 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . 83.9 t90 -25.37 125.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.737 0.648 . . . . 0.0 111.742 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -166.78 -155.58 9.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.945 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -64.1 -48.91 74.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.569 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 5.9 pt-20 -63.8 149.01 47.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.658 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 41.62 16.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.207 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' GLU . 43.2 t0 49.41 17.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.679 ' N ' HD21 ' A' ' 9' ' ' ASN . 87.5 t90 -140.26 10.77 2.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.685 ' N ' HD22 ' A' ' 9' ' ' ASN . 1.1 m -163.03 162.05 25.73 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 1' ' ' GLY . 7.1 t -96.47 147.63 23.64 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.0 -123.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.589 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -82.05 -43.04 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.97 156.11 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.96 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.401 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -38.38 102.63 0.25 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.641 -0.219 . . . . 0.0 110.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -46.0 102.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.053 1.836 . . . . 0.0 112.396 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -179.83 23.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.792 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' ASN . 82.6 t90 48.52 106.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.113 0.482 . . . . 0.0 111.258 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 12' ' ' SER . . . -136.08 -92.14 0.34 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' SER . 80.6 m-85 -146.67 -35.76 0.25 Allowed 'General case' 0 N--CA 1.462 0.154 0 O-C-N 122.782 -0.246 . . . . 0.0 111.49 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.547 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -47.09 -105.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.092 0.472 . . . . 0.0 111.581 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.754 ' ND2' ' H ' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -75.17 29.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.816 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 8' ' ' GLU . 92.1 m-20 56.33 -1.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.754 ' H ' ' ND2' ' A' ' 9' ' ' ASN . 16.3 t90 -119.94 9.26 11.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.98 -173.66 1.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.3 t -112.91 165.23 12.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.384 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -87.56 -169.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 110.488 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -60.05 -43.57 95.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 11.8 t -95.85 115.58 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.272 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 73.6 m . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.497 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.232 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.493 ' HE ' HD22 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.75 151.34 39.89 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 117.082 0.441 . . . . 0.0 111.024 -178.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.06 111.43 2.44 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.15 2.567 . . . . 0.0 112.363 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.493 HD22 ' HE ' ' A' ' 2' ' ' ARG . 4.9 p30 175.62 21.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.727 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.7 t90 41.63 69.69 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.958 0.409 . . . . 0.0 110.13 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.67 -85.87 1.89 Allowed Glycine 0 N--CA 1.463 0.449 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.948 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.75 -41.84 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.705 0.252 . . . . 0.0 111.409 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.599 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.0 pt-20 -67.53 148.37 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.508 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.681 HD21 ' N ' ' A' ' 11' ' ' TRP . 0.6 OUTLIER 40.07 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.027 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 50.83 22.84 1.24 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.721 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.681 ' N ' HD21 ' A' ' 9' ' ' ASN . 80.3 m95 -144.02 7.16 1.39 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 110.401 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.609 ' N ' HD22 ' A' ' 9' ' ' ASN . 2.3 m -159.36 166.42 31.17 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.918 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -104.55 154.02 20.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 111.057 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 15' ' ' ARG . 35.2 m -76.88 -54.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 17' ' ' CYS . 67.2 ttt180 -173.16 163.53 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 17' ' ' CYS . 92.0 t 55.45 -86.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' ARG . 12.0 m . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' ASN . 37.0 mtp85 -129.23 93.75 35.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.893 -0.181 . . . . 0.0 111.167 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.36 83.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.657 2.238 . . . . 0.0 112.915 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' ARG . 14.1 t-20 -172.69 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.748 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 10.0 m0 53.55 107.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.96 -130.34 1.18 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' SER . 78.2 m-85 -88.71 -65.62 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 2.5 pt-20 -48.66 147.66 2.46 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.435 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.738 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.82 17.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.922 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.4 t0 48.87 11.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.413 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.738 ' H ' HD21 ' A' ' 9' ' ' ASN . 83.6 m95 -133.57 15.31 4.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.601 ' N ' HD22 ' A' ' 9' ' ' ASN . 3.9 m -162.23 162.2 28.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.388 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.51 155.05 18.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.785 0.326 . . . . 0.0 110.311 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -94.38 -162.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.338 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -55.07 -43.48 73.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.688 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.3 108.46 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 110.465 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 36.5 t . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.435 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -38.71 102.04 0.24 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.986 -0.107 . . . . 0.0 111.132 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.41 100.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.075 1.85 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' TRP . 45.4 t-20 -172.89 23.92 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.602 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.495 ' HE1' ' HE1' ' A' ' 11' ' ' TRP . 5.3 m-90 51.5 104.22 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.445 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -158.78 -148.85 5.32 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.21 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.1 -56.45 6.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -58.09 148.81 25.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.385 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.7 HD22 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 42.06 16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.9 m-20 47.06 22.85 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.685 ' N ' HD21 ' A' ' 9' ' ' ASN . 82.6 t90 -144.5 10.38 1.43 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.668 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.7 ' N ' HD22 ' A' ' 9' ' ' ASN . 4.3 m -162.73 162.96 27.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 2' ' ' ARG . 5.0 m -91.75 158.17 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.72 0.295 . . . . 0.0 111.02 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 m -78.75 -37.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.53 -72.06 0.32 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 m -122.25 131.42 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.143 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.488 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.262 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.486 ' O ' ' N ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -174.94 104.09 0.26 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.956 0.378 . . . . 0.0 111.415 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.53 86.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.294 1.996 . . . . 0.0 112.658 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.6 m-20 -159.62 28.58 0.19 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 84.3 t90 47.63 91.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.42 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -143.13 -143.98 4.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -76.73 -57.83 3.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -54.64 143.59 24.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.224 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.776 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.8 OUTLIER 41.8 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.638 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 8' ' ' GLU . 42.3 t0 54.46 -0.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.655 0.264 . . . . 0.0 110.96 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.776 ' H ' HD21 ' A' ' 9' ' ' ASN . 3.3 m0 -112.88 0.4 15.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.803 0.335 . . . . 0.0 110.478 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.553 ' N ' HD22 ' A' ' 9' ' ' ASN . 4.2 p -159.29 166.81 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.222 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 10.6 t -99.22 163.39 12.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 32.8 m -90.97 -156.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -83.05 -47.63 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' CYS . 86.2 t -63.83 -46.79 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.349 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 14' ' ' VAL . 85.0 m . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.036 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.804 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.626 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -54.31 151.05 14.39 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.49 -178.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.98 99.85 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.674 2.249 . . . . 0.0 112.493 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.675 ' ND2' ' H ' ' A' ' 5' ' ' TRP . 14.7 t30 -174.98 -128.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.396 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.675 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 52.7 p-90 -161.48 99.72 1.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . . . -141.15 -156.83 6.95 Favored Glycine 0 N--CA 1.466 0.633 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.65 -38.5 89.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.006 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -70.29 145.03 51.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.53 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.54 ' ND2' ' CB ' ' A' ' 11' ' ' TRP . 5.4 t30 46.7 12.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 110.782 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' GLU . 6.0 p-10 43.07 19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.54 ' CB ' ' ND2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.79 19.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.629 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' GLY . 3.6 m -147.13 150.15 34.41 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 110.258 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' ' ND2' ' A' ' 4' ' ' ASN . 1.1 m -63.51 151.71 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.27 -45.59 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.429 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -140.77 -84.87 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.973 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.19 9.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.495 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.702 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -132.08 92.4 29.46 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.26 85.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.305 2.003 . . . . 0.0 112.898 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.2 m-20 -160.55 32.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 54.26 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.547 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -155.28 -139.21 2.73 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.4 m-85 -80.35 -79.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.521 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -48.33 161.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.756 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' C ' ' H ' ' A' ' 11' ' ' TRP . 25.9 t30 55.61 7.66 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 109.997 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.9 m-20 57.83 9.9 0.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.43 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 4.4 m-90 -160.16 29.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.547 ' N ' ' H ' ' A' ' 6' ' ' GLY . 67.1 m -153.29 147.88 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 14' ' ' VAL . 1.2 t -71.72 164.35 26.12 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -92.2 -165.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -55.45 -43.1 75.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 110.472 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.33 131.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.609 179.743 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.496 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.6 ptm85 -170.2 153.92 4.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.558 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.87 167.01 2.51 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.74 2.294 . . . . 0.0 112.142 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 37.1 t30 76.1 155.58 0.17 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.123 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 12.3 m0 -74.13 132.09 41.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.34 -137.21 2.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' SER . 94.7 m-85 -87.07 -83.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.679 0.276 . . . . 0.0 111.662 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.6 pt-20 -44.02 159.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.855 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 11' ' ' TRP . 20.4 t30 53.88 12.2 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.129 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 68.8 m-20 57.57 7.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.114 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 5.0 m-90 -159.34 35.65 0.2 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.49 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 7' ' ' PHE . 38.7 m -158.52 140.78 14.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.404 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.1 m -68.87 158.31 34.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.032 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.55 -143.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.397 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -59.32 -43.31 92.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 t -131.13 124.87 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.373 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.315 179.721 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.509 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -82.35 156.36 68.8 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.847 0.356 . . . . 0.0 111.058 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 34.3 Cg_endo -62.07 169.68 7.28 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.604 2.203 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 83.36 114.4 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.209 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 42.2 p90 -37.82 120.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.07 -142.69 3.69 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.2 m-85 -80.82 -73.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.507 ' C ' ' H ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -49.41 152.78 1.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.812 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.557 ' C ' ' H ' ' A' ' 11' ' ' TRP . 8.2 t30 54.24 8.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.214 0.531 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 55.75 5.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.942 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.557 ' H ' ' C ' ' A' ' 9' ' ' ASN . 2.7 t-105 -142.66 21.23 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.17 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 13' ' ' CYS . 2.1 t -154.35 153.53 31.77 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.312 0.577 . . . . 0.0 110.388 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.689 ' N ' ' HG ' ' A' ' 12' ' ' SER . 5.9 m -83.74 159.94 21.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.394 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.4 m -80.4 -39.1 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -145.03 -65.07 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.37 131.3 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.627 -179.783 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' PRO . 16.0 mtp85 -82.45 141.39 45.49 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' ARG . 76.6 Cg_exo -41.12 172.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.721 2.281 . . . . 0.0 112.454 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' PRO . 76.9 m-20 58.3 121.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.816 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -41.15 135.31 1.88 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.88 -139.22 3.03 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -85.19 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 111.097 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' ASP . 7.2 pt-20 -50.32 145.93 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.732 HD21 ' N ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 40.98 17.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.284 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.3 t0 46.25 15.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.732 ' N ' HD21 ' A' ' 9' ' ' ASN . 69.2 t90 -135.83 12.28 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.702 ' N ' HD22 ' A' ' 9' ' ' ASN . 2.5 m -164.22 166.23 21.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.259 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 8' ' ' GLU . 7.8 m -98.03 149.72 22.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.96 -23.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.037 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -167.68 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.84 133.99 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.769 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.704 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.62 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -72.79 154.36 91.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 0.0 110.702 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.29 -22.44 60.42 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.96 2.44 . . . . 0.0 112.519 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 5' ' ' TRP . 98.4 m-20 -68.7 118.97 12.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 4' ' ' ASN . 62.5 p-90 -32.89 141.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.598 0.561 . . . . 0.0 111.227 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.75 -135.37 2.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.292 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' SER . 89.9 m-85 -86.4 -62.49 1.5 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' C ' ' N ' ' A' ' 10' ' ' ASP . 4.2 pt-20 -50.98 162.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.227 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.507 ' C ' ' H ' ' A' ' 11' ' ' TRP . 12.8 t30 46.38 18.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.539 0.685 . . . . 0.0 110.144 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 8' ' ' GLU . 24.4 t0 51.45 11.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.507 ' H ' ' C ' ' A' ' 9' ' ' ASN . 59.2 t-105 -159.45 37.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -167.48 151.04 6.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -81.05 158.98 24.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -98.28 -168.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.955 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -52.02 -44.32 64.12 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.314 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.65 122.94 56.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.468 -179.892 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.622 ' H ' ' CB ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.678 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.73 148.01 64.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 122.968 -0.136 . . . . 0.0 110.775 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 2' ' ' ARG . 50.8 Cg_exo -40.55 179.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.747 2.298 . . . . 0.0 112.468 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 4.4 m-20 79.2 98.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASN . 42.5 p-90 -35.53 121.94 0.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.21 -130.75 2.53 Favored Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -93.64 -68.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.56 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 6.7 pt-20 -46.26 145.08 1.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.748 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.31 18.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.867 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 45.84 13.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.946 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.748 ' H ' HD21 ' A' ' 9' ' ' ASN . 78.6 m95 -133.53 11.11 4.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.727 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.698 ' N ' HD22 ' A' ' 9' ' ' ASN . 3.7 m -159.95 162.76 34.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.911 0.386 . . . . 0.0 110.849 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.642 ' CB ' ' HE ' ' A' ' 2' ' ' ARG . 5.6 m -89.58 159.73 17.03 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 121.371 0.605 . . . . 0.0 111.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.4 m -97.26 -118.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.456 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.4 ttm180 -67.55 -55.9 11.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.302 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.97 164.92 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.432 179.496 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.467 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -89.61 159.1 44.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 2' ' ' ARG . 13.7 Cg_endo -54.2 -162.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.839 2.359 . . . . 0.0 112.085 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.41 113.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 66.6 p-90 -40.16 125.49 2.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.842 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.3 -136.71 2.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.3 m-85 -90.97 -70.8 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 10' ' ' ASP . 5.6 pt-20 -49.67 150.92 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.55 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.456 ' C ' ' H ' ' A' ' 11' ' ' TRP . 9.9 t30 55.57 6.2 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.023 0.44 . . . . 0.0 110.315 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 8' ' ' GLU . 20.7 t70 63.09 2.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.353 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.456 ' H ' ' C ' ' A' ' 9' ' ' ASN . 5.7 t90 -146.86 26.85 1.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.708 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.9 m -153.97 147.27 24.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -80.36 165.75 21.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.102 -179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.39 -172.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.187 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.43 140.73 58.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.269 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 t 67.82 59.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.201 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.483 -179.609 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.474 ' CG ' ' O ' ' A' ' 13' ' ' CYS . 4.5 ptm180 -173.36 154.4 2.53 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 26.3 Cg_endo -59.78 156.27 38.85 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.509 2.139 . . . . 0.0 112.228 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 90.13 110.21 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.329 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -40.53 114.53 0.47 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -138.43 -142.03 4.25 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' SER . 96.8 m-85 -80.69 -64.65 1.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.6 pt-20 -57.03 147.55 23.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.003 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 11' ' ' TRP . 5.8 t30 56.33 5.22 0.17 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' H ' ' C ' ' A' ' 8' ' ' GLU . 48.6 t0 62.19 -0.12 0.52 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.528 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -134.47 20.74 3.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 7' ' ' PHE . 5.7 p -156.58 155.25 31.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 1.6 m -86.9 152.3 22.56 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -77.06 -92.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.814 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' H ' HG23 ' A' ' 14' ' ' VAL . 78.7 ttt-85 -131.21 -21.93 2.57 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 53.4 t -121.67 131.92 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 1.7 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.168 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.637 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.71 146.96 65.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.775 -0.25 . . . . 0.0 111.658 -178.382 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.75 110.46 0.97 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.685 2.257 . . . . 0.0 112.329 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 56.5 t-20 -173.72 17.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 42.37 56.72 3.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.004 0.431 . . . . 0.0 110.405 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.432 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -85.6 -91.85 0.85 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.674 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' SER . 90.0 m-85 -154.1 -19.25 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.527 ' C ' ' H ' ' A' ' 10' ' ' ASP . 1.4 pt-20 -59.1 -103.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.277 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.75 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -70.18 38.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 8' ' ' GLU . 5.8 p-10 43.79 21.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 110.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.75 ' H ' HD21 ' A' ' 9' ' ' ASN . 76.8 t90 -152.06 8.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.707 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.544 ' N ' HD22 ' A' ' 9' ' ' ASN . 2.5 m -158.13 176.22 12.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 1' ' ' GLY . 47.9 t -105.95 160.64 15.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.056 0.455 . . . . 0.0 110.9 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.2 m -81.6 -174.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.695 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -59.26 -45.62 90.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.95 107.33 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.845 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.2 m . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.609 -179.534 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' NH2' ' O ' ' A' ' 15' ' ' ARG . 8.3 mtp180 -128.92 145.68 57.47 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.38 84.99 0.9 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.77 2.313 . . . . 0.0 112.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 64.0 t30 -174.41 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.269 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.406 ' H ' ' CG ' ' A' ' 4' ' ' ASN . 15.0 t90 -175.64 102.53 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.804 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -138.44 -48.56 0.06 OUTLIER Glycine 0 N--CA 1.466 0.646 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.598 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 94.5 m-85 -159.68 -60.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.573 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.524 ' C ' ' H ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -52.87 148.13 8.06 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.789 -177.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.593 HD22 ' CB ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 53.61 8.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.869 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 53.42 21.7 2.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.593 ' CB ' HD22 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -157.42 9.96 0.19 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.53 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -142.12 161.16 38.7 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.27 147.15 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.874 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.94 151.77 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.49 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.497 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 15.4 tpp180 42.94 -129.26 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' H ' ' CG ' ' A' ' 15' ' ' ARG . 96.7 t -63.95 -46.29 94.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.819 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.503 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.537 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -111.2 146.65 34.98 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.853 0.327 . . . . 0.0 111.5 -178.736 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 70.2 Cg_endo -71.26 86.96 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.677 2.252 . . . . 0.0 111.723 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 3' ' ' PRO . 17.7 m120 -155.5 25.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' ASN . 88.4 t90 47.57 98.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.463 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -150.46 -141.94 3.46 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.263 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.0 m-85 -81.27 -54.22 5.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.4 pt-20 -68.19 151.92 46.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.65 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 11' ' ' TRP . 4.8 t30 55.03 6.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.114 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 8' ' ' GLU . 99.0 m-20 57.88 2.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.556 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 t-105 -139.47 20.85 2.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 2' ' ' ARG . 11.2 t -153.8 158.62 41.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.414 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' N ' ' HG ' ' A' ' 12' ' ' SER . 0.8 OUTLIER -95.96 155.59 16.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.466 ' CG2' ' N ' ' A' ' 15' ' ' ARG . 9.8 m -65.97 -44.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.09 0.472 . . . . 0.0 110.15 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.483 ' O ' ' CZ ' ' A' ' 2' ' ' ARG . 26.5 tpt85 -157.48 -38.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.715 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.68 131.7 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.448 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -79.7 158.71 72.89 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.956 0.408 . . . . 0.0 110.782 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.88 -20.92 58.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.602 2.201 . . . . 0.0 111.526 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.446 ' O ' ' OG ' ' A' ' 12' ' ' SER . 28.6 m120 -64.59 -169.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.79 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 16.3 p90 -107.04 141.05 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.869 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.484 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.71 -123.36 0.77 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.2 m-85 -99.23 -67.56 0.84 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -53.84 176.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.668 ' ND2' ' CD1' ' A' ' 11' ' ' TRP . 34.6 t30 48.43 16.2 0.1 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLU . 57.2 m-20 69.56 -10.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.052 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.668 ' CD1' ' ND2' ' A' ' 9' ' ' ASN . 1.2 p90 -166.43 73.14 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.529 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 7' ' ' PHE . 18.8 m -171.28 144.87 2.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.16 159.05 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 29.1 m -81.87 -160.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.813 0.339 . . . . 0.0 110.473 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.26 130.38 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.453 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.583 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -101.83 103.94 32.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 122.592 -0.358 . . . . 0.0 110.883 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.06 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.091 1.861 . . . . 0.0 112.188 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -173.0 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.838 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 44.02 88.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.317 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -134.98 -125.4 2.53 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.3 m-85 -94.33 -66.2 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.559 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 3.5 pt-20 -51.89 146.05 8.92 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.214 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.699 HD21 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 43.14 15.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.854 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.1 m-20 46.65 14.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.181 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.699 ' H ' HD21 ' A' ' 9' ' ' ASN . 13.3 t-105 -126.71 2.73 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.969 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.694 ' HG ' HD22 ' A' ' 9' ' ' ASN . 10.2 p -159.7 165.53 32.4 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.984 0.421 . . . . 0.0 111.444 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.5 t -90.2 160.93 15.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.769 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -71.08 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.422 ' O ' ' O ' ' A' ' 16' ' ' VAL . 42.0 ttp85 -139.32 119.67 13.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 15' ' ' ARG . 35.3 t 53.53 107.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.9 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.526 179.801 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.433 ' C ' ' H ' ' A' ' 4' ' ' ASN . 3.3 mtp85 -60.65 146.09 86.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 120.436 0.16 . . . . 0.0 111.011 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.12 25.46 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.897 2.398 . . . . 0.0 113.01 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' TRP . 13.9 m120 -126.48 120.38 29.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 121.44 -0.104 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . 83.9 t90 -25.37 125.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.737 0.648 . . . . 0.0 111.742 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -166.78 -155.58 9.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.945 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -64.1 -48.91 74.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.569 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 5.9 pt-20 -63.8 149.01 47.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.658 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 41.62 16.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.207 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' GLU . 43.2 t0 49.41 17.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.679 ' N ' HD21 ' A' ' 9' ' ' ASN . 87.5 t90 -140.26 10.77 2.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.685 ' N ' HD22 ' A' ' 9' ' ' ASN . 1.1 m -163.03 162.05 25.73 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 1' ' ' GLY . 7.1 t -96.47 147.63 23.64 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.0 -123.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.589 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -82.05 -43.04 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.97 156.11 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.96 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.401 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -38.38 102.63 0.25 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.641 -0.219 . . . . 0.0 110.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -46.0 102.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.053 1.836 . . . . 0.0 112.396 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -179.83 23.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.792 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' ASN . 82.6 t90 48.52 106.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.113 0.482 . . . . 0.0 111.258 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 12' ' ' SER . . . -136.08 -92.14 0.34 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' SER . 80.6 m-85 -146.67 -35.76 0.25 Allowed 'General case' 0 N--CA 1.462 0.154 0 O-C-N 122.782 -0.246 . . . . 0.0 111.49 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.547 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -47.09 -105.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.092 0.472 . . . . 0.0 111.581 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.754 ' ND2' ' H ' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -75.17 29.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.816 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 8' ' ' GLU . 92.1 m-20 56.33 -1.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.754 ' H ' ' ND2' ' A' ' 9' ' ' ASN . 16.3 t90 -119.94 9.26 11.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.98 -173.66 1.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.3 t -112.91 165.23 12.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.384 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -87.56 -169.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 110.488 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -60.05 -43.57 95.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 11.8 t -95.85 115.58 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.272 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 73.6 m . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.497 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.232 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.548 ' HE ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.75 151.34 39.89 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 117.082 0.441 . . . . 0.0 111.024 -178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.06 111.43 2.44 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.15 2.567 . . . . 0.0 112.363 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.548 HD21 ' HE ' ' A' ' 2' ' ' ARG . 4.9 p30 175.62 21.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.727 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.7 t90 41.63 69.69 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.958 0.409 . . . . 0.0 110.13 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -100.67 -85.87 1.89 Allowed Glycine 0 N--CA 1.463 0.449 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.948 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.75 -41.84 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.705 0.252 . . . . 0.0 111.409 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.599 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.0 pt-20 -67.53 148.37 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.508 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.584 HD22 ' HB2' ' A' ' 12' ' ' SER . 12.3 p30 40.07 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 50.83 22.84 1.24 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.721 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -144.02 7.16 1.39 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 110.401 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.584 ' HB2' HD22 ' A' ' 9' ' ' ASN . 2.3 m -159.36 166.42 31.17 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.918 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -104.55 154.02 20.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 111.057 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 15' ' ' ARG . 35.2 m -76.88 -54.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.645 ' N ' HG23 ' A' ' 14' ' ' VAL . 67.2 ttt180 -173.16 163.53 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 17' ' ' CYS . 92.0 t 55.45 -86.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' ARG . 12.0 m . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' ASN . 37.0 mtp85 -129.23 93.75 35.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.893 -0.181 . . . . 0.0 111.167 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.36 83.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.657 2.238 . . . . 0.0 112.915 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 3.6 t30 -172.69 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.748 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 10.0 m0 53.55 107.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.96 -130.34 1.18 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' SER . 78.2 m-85 -88.71 -65.62 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.577 ' OE1' ' ND2' ' A' ' 9' ' ' ASN . 2.5 pt-20 -48.66 147.66 2.46 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.435 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.664 HD22 ' HB2' ' A' ' 12' ' ' SER . 11.6 p30 41.82 17.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.4 t0 48.87 11.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.413 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' ASN . 83.6 m95 -133.57 15.31 4.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.664 ' HB2' HD22 ' A' ' 9' ' ' ASN . 3.9 m -162.23 162.2 28.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.388 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.51 155.05 18.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.785 0.326 . . . . 0.0 110.311 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 14' ' ' VAL . 15.5 m -94.38 -162.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.338 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -55.07 -43.48 73.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.688 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.3 108.46 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 110.465 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 36.5 t . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.435 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' HD22 ' A' ' 9' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -38.71 102.04 0.24 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.986 -0.107 . . . . 0.0 111.132 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.41 100.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.075 1.85 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' TRP . 45.4 t-20 -172.89 23.92 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.602 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.536 ' HE1' ' HE1' ' A' ' 11' ' ' TRP . 5.3 m-90 51.5 104.22 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -158.78 -148.85 5.32 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.21 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.1 -56.45 6.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -58.09 148.81 25.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.385 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.616 HD22 ' HB2' ' A' ' 12' ' ' SER . 8.2 p30 42.06 16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.9 m-20 47.06 22.85 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.536 ' HE1' ' HE1' ' A' ' 5' ' ' TRP . 82.6 t90 -144.5 10.38 1.43 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.668 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.616 ' HB2' HD22 ' A' ' 9' ' ' ASN . 4.3 m -162.73 162.96 27.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 2' ' ' ARG . 5.0 m -91.75 158.17 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.72 0.295 . . . . 0.0 111.02 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 m -78.75 -37.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.53 -72.06 0.32 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 m -122.25 131.42 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.143 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.488 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.262 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.548 ' H ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -174.94 104.09 0.26 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.956 0.378 . . . . 0.0 111.415 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.53 86.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.294 1.996 . . . . 0.0 112.658 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.6 m-20 -159.62 28.58 0.19 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 84.3 t90 47.63 91.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -143.13 -143.98 4.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.421 ' H ' ' HA ' ' A' ' 13' ' ' CYS . 96.9 m-85 -76.73 -57.83 3.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -54.64 143.59 24.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.224 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 11' ' ' TRP . 6.0 p30 41.8 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.638 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 8' ' ' GLU . 42.3 t0 54.46 -0.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.655 0.264 . . . . 0.0 110.96 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.586 ' H ' ' C ' ' A' ' 9' ' ' ASN . 3.3 m0 -112.88 0.4 15.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.803 0.335 . . . . 0.0 110.478 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.548 ' HB2' ' H ' ' A' ' 2' ' ' ARG . 4.2 p -159.29 166.81 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.222 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 10.6 t -99.22 163.39 12.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 32.8 m -90.97 -156.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -83.05 -47.63 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' CYS . 86.2 t -63.83 -46.79 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.349 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 14' ' ' VAL . 85.0 m . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.036 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.804 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.709 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -54.31 151.05 14.39 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.49 -178.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.98 99.85 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.674 2.249 . . . . 0.0 112.493 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.438 ' OD1' ' SG ' ' A' ' 13' ' ' CYS . 8.1 t-20 -174.98 -128.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.396 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 52.7 p-90 -161.48 99.72 1.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . . . -141.15 -156.83 6.95 Favored Glycine 0 N--CA 1.466 0.633 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.65 -38.5 89.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.006 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -70.29 145.03 51.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.53 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 11' ' ' TRP . 14.2 t-20 46.7 12.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 110.782 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' GLU . 6.0 p-10 43.07 19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.79 19.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.629 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' GLY . 3.6 m -147.13 150.15 34.41 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 110.258 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.438 ' SG ' ' OD1' ' A' ' 4' ' ' ASN . 1.1 m -63.51 151.71 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.27 -45.59 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.429 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -140.77 -84.87 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.973 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.19 9.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.495 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.702 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -132.08 92.4 29.46 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.26 85.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.305 2.003 . . . . 0.0 112.898 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.2 m-20 -160.55 32.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 54.26 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.587 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -155.28 -139.21 2.73 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.4 m-85 -80.35 -79.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -48.33 161.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.756 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.408 ' C ' ' N ' ' A' ' 11' ' ' TRP . 23.2 t-20 55.61 7.66 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 109.997 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 98.9 m-20 57.83 9.9 0.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.43 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 4.4 m-90 -160.16 29.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.587 ' N ' ' H ' ' A' ' 6' ' ' GLY . 67.1 m -153.29 147.88 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 14' ' ' VAL . 1.2 t -71.72 164.35 26.12 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -92.2 -165.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -55.45 -43.1 75.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 110.472 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.33 131.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.609 179.743 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.6 ptm85 -170.2 153.92 4.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.558 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.87 167.01 2.51 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.74 2.294 . . . . 0.0 112.142 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 37.1 t30 76.1 155.58 0.17 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.123 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 12.3 m0 -74.13 132.09 41.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -156.34 -137.21 2.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' SER . 94.7 m-85 -87.07 -83.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.679 0.276 . . . . 0.0 111.662 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.6 pt-20 -44.02 159.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.855 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' TRP . 24.2 t-20 53.88 12.2 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.129 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 68.8 m-20 57.57 7.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.114 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 5.0 m-90 -159.34 35.65 0.2 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.49 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 7' ' ' PHE . 38.7 m -158.52 140.78 14.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.1 m -68.87 158.31 34.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.032 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 16' ' ' VAL . 33.5 m -67.55 -143.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.397 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -59.32 -43.31 92.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 14' ' ' VAL . 2.4 t -131.13 124.87 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.315 179.721 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.509 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.508 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -82.35 156.36 68.8 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.847 0.356 . . . . 0.0 111.058 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 34.3 Cg_endo -62.07 169.68 7.28 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.604 2.203 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 83.36 114.4 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.209 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 42.2 p90 -37.82 120.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -148.07 -142.69 3.69 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.2 m-85 -80.82 -73.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -49.41 152.78 1.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.812 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 11' ' ' TRP . 22.9 t-20 54.24 8.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.214 0.531 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 55.75 5.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.942 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 9' ' ' ASN . 2.7 t-105 -142.66 21.23 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.17 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.1 t -154.35 153.53 31.77 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.312 0.577 . . . . 0.0 110.388 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.9 m -83.74 159.94 21.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.394 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 14' ' ' VAL . 2.4 m -80.4 -39.1 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -145.03 -65.07 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.37 131.3 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.627 -179.783 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.564 ' N ' HD22 ' A' ' 9' ' ' ASN . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' PRO . 16.0 mtp85 -82.45 141.39 45.49 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' ARG . 76.6 Cg_exo -41.12 172.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.721 2.281 . . . . 0.0 112.454 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' PRO . 76.9 m-20 58.3 121.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.816 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -41.15 135.31 1.88 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.88 -139.22 3.03 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -85.19 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 111.097 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' ASP . 7.2 pt-20 -50.32 145.93 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.7 HD22 ' HB2' ' A' ' 12' ' ' SER . 12.7 p30 40.98 17.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.284 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.3 t0 46.25 15.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.522 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 69.2 t90 -135.83 12.28 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.7 ' HB2' HD22 ' A' ' 9' ' ' ASN . 2.5 m -164.22 166.23 21.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.259 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 8' ' ' GLU . 7.8 m -98.03 149.72 22.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.96 -23.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.037 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -167.68 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.84 133.99 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.769 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.704 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.673 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -72.79 154.36 91.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 0.0 110.702 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.29 -22.44 60.42 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.96 2.44 . . . . 0.0 112.519 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 5' ' ' TRP . 98.4 m-20 -68.7 118.97 12.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 4' ' ' ASN . 62.5 p-90 -32.89 141.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.598 0.561 . . . . 0.0 111.227 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.75 -135.37 2.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.292 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' SER . 89.9 m-85 -86.4 -62.49 1.5 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' C ' ' N ' ' A' ' 10' ' ' ASP . 4.2 pt-20 -50.98 162.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.227 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 11' ' ' TRP . 10.9 t-20 46.38 18.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.539 0.685 . . . . 0.0 110.144 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 8' ' ' GLU . 24.4 t0 51.45 11.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 11' ' ' TRP . 59.2 t-105 -159.45 37.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -167.48 151.04 6.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -81.05 158.98 24.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -98.28 -168.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.955 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -52.02 -44.32 64.12 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.314 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.65 122.94 56.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.468 -179.892 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.783 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.73 148.01 64.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 122.968 -0.136 . . . . 0.0 110.775 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 2' ' ' ARG . 50.8 Cg_exo -40.55 179.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.747 2.298 . . . . 0.0 112.468 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 4.4 m-20 79.2 98.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASN . 42.5 p-90 -35.53 121.94 0.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.21 -130.75 2.53 Favored Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -93.64 -68.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.7 pt-20 -46.26 145.08 1.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.704 HD22 ' HB2' ' A' ' 12' ' ' SER . 13.3 p30 41.31 18.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.867 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 45.84 13.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.946 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.513 ' N ' ' O ' ' A' ' 9' ' ' ASN . 78.6 m95 -133.53 11.11 4.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.727 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.704 ' HB2' HD22 ' A' ' 9' ' ' ASN . 3.7 m -159.95 162.76 34.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.911 0.386 . . . . 0.0 110.849 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.678 ' CB ' ' HE ' ' A' ' 2' ' ' ARG . 5.6 m -89.58 159.73 17.03 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 121.371 0.605 . . . . 0.0 111.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 15' ' ' ARG . 6.4 m -97.26 -118.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.456 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 14' ' ' VAL . 36.4 ttm180 -67.55 -55.9 11.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.302 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.97 164.92 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.432 179.496 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -89.61 159.1 44.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 2' ' ' ARG . 13.7 Cg_endo -54.2 -162.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.839 2.359 . . . . 0.0 112.085 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.41 113.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 66.6 p-90 -40.16 125.49 2.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.842 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.403 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -149.3 -136.71 2.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.3 m-85 -90.97 -70.8 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 10' ' ' ASP . 5.6 pt-20 -49.67 150.92 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.55 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' TRP . 21.5 t-20 55.57 6.2 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.023 0.44 . . . . 0.0 110.315 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 8' ' ' GLU . 20.7 t70 63.09 2.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.353 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' ASN . 5.7 t90 -146.86 26.85 1.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.708 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.9 m -153.97 147.27 24.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -80.36 165.75 21.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.102 -179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.39 -172.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.187 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.43 140.73 58.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.269 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 t 67.82 59.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.201 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.483 -179.609 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.492 ' H ' ' HB2' ' A' ' 12' ' ' SER . 4.5 ptm180 -173.36 154.4 2.53 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 26.3 Cg_endo -59.78 156.27 38.85 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.509 2.139 . . . . 0.0 112.228 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 90.13 110.21 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.329 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -40.53 114.53 0.47 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.566 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -138.43 -142.03 4.25 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' SER . 96.8 m-85 -80.69 -64.65 1.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.6 pt-20 -57.03 147.55 23.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.003 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' TRP . 17.4 t-20 56.33 5.22 0.17 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 8' ' ' GLU . 48.6 t0 62.19 -0.12 0.52 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -134.47 20.74 3.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.566 ' N ' ' H ' ' A' ' 6' ' ' GLY . 5.7 p -156.58 155.25 31.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 1.6 m -86.9 152.3 22.56 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -77.06 -92.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.814 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' H ' HG23 ' A' ' 14' ' ' VAL . 78.7 ttt-85 -131.21 -21.93 2.57 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 53.4 t -121.67 131.92 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 1.7 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.168 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.728 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.71 146.96 65.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.775 -0.25 . . . . 0.0 111.658 -178.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.75 110.46 0.97 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.685 2.257 . . . . 0.0 112.329 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 56.5 t-20 -173.72 17.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 42.37 56.72 3.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.004 0.431 . . . . 0.0 110.405 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -85.6 -91.85 0.85 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.674 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' SER . 90.0 m-85 -154.1 -19.25 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' A' ' 9' ' ' ASN . 1.4 pt-20 -59.1 -103.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.277 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' A' ' 8' ' ' GLU . 21.5 p30 -70.18 38.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 8' ' ' GLU . 5.8 p-10 43.79 21.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 110.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 9' ' ' ASN . 76.8 t90 -152.06 8.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.707 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.5 m -158.13 176.22 12.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 1' ' ' GLY . 47.9 t -105.95 160.64 15.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.056 0.455 . . . . 0.0 110.9 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 14' ' ' VAL . 7.2 m -81.6 -174.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -59.26 -45.62 90.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.95 107.33 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.845 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.2 m . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.609 -179.534 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.497 ' NH2' ' O ' ' A' ' 15' ' ' ARG . 8.3 mtp180 -128.92 145.68 57.47 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.38 84.99 0.9 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.77 2.313 . . . . 0.0 112.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 64.0 t30 -174.41 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.269 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -175.64 102.53 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.804 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -138.44 -48.56 0.06 OUTLIER Glycine 0 N--CA 1.466 0.646 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.598 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 94.5 m-85 -159.68 -60.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.573 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -52.87 148.13 8.06 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.789 -177.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER 53.61 8.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.869 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 53.42 21.7 2.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -157.42 9.96 0.19 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.53 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -142.12 161.16 38.7 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.27 147.15 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.874 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.94 151.77 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.49 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.497 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 15.4 tpp180 42.94 -129.26 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.425 ' O ' ' OXT' ' A' ' 17' ' ' CYS . 96.7 t -63.95 -46.29 94.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.819 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.503 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.537 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -111.2 146.65 34.98 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.853 0.327 . . . . 0.0 111.5 -178.736 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.26 86.96 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.677 2.252 . . . . 0.0 111.723 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' TRP . 82.2 m-20 -155.5 25.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' ASN . 88.4 t90 47.57 98.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.498 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -150.46 -141.94 3.46 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.263 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.0 m-85 -81.27 -54.22 5.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.4 pt-20 -68.19 151.92 46.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.65 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 11' ' ' TRP . 14.0 t-20 55.03 6.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.114 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLU . 99.0 m-20 57.88 2.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.541 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 t-105 -139.47 20.85 2.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 2' ' ' ARG . 11.2 t -153.8 158.62 41.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.414 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.96 155.59 16.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 15' ' ' ARG . 9.8 m -65.97 -44.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.09 0.472 . . . . 0.0 110.15 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 14' ' ' VAL . 26.5 tpt85 -157.48 -38.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.715 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.68 131.7 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.483 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.7 158.71 72.89 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.956 0.408 . . . . 0.0 110.782 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.88 -20.92 58.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.602 2.201 . . . . 0.0 111.526 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -64.59 -169.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 16.3 p90 -107.04 141.05 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.869 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.71 -123.36 0.77 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.2 m-85 -99.23 -67.56 0.84 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -53.84 176.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 11' ' ' TRP . 19.2 t-20 48.43 16.2 0.1 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' N ' ' C ' ' A' ' 8' ' ' GLU . 57.2 m-20 69.56 -10.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.052 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.541 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 p90 -166.43 73.14 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.529 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.51 ' N ' ' H ' ' A' ' 6' ' ' GLY . 18.8 m -171.28 144.87 2.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.16 159.05 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 29.1 m -81.87 -160.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.813 0.339 . . . . 0.0 110.473 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.26 130.38 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.453 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.583 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -101.83 103.94 32.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 122.592 -0.358 . . . . 0.0 110.883 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.06 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.091 1.861 . . . . 0.0 112.188 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -173.0 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.838 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 44.02 88.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.317 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -134.98 -125.4 2.53 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.3 m-85 -94.33 -66.2 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 10' ' ' ASP . 3.5 pt-20 -51.89 146.05 8.92 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.214 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.564 ' ND2' ' OG ' ' A' ' 12' ' ' SER . 7.9 p30 43.14 15.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.854 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.1 m-20 46.65 14.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.181 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' ASN . 13.3 t-105 -126.71 2.73 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.969 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.564 ' OG ' ' ND2' ' A' ' 9' ' ' ASN . 10.2 p -159.7 165.53 32.4 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.984 0.421 . . . . 0.0 111.444 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.5 t -90.2 160.93 15.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.769 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -71.08 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' H ' HG23 ' A' ' 14' ' ' VAL . 42.0 ttp85 -139.32 119.67 13.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 15' ' ' ARG . 35.3 t 53.53 107.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.9 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.526 179.801 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -60.65 146.09 86.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 120.436 0.16 . . . . 0.0 111.011 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.12 25.46 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.897 2.398 . . . . 0.0 113.01 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' TRP . 87.4 m-20 -126.48 120.38 29.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 121.44 -0.104 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . 83.9 t90 -25.37 125.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.737 0.648 . . . . 0.0 111.742 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -166.78 -155.58 9.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.945 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -64.1 -48.91 74.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.9 pt-20 -63.8 149.01 47.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.658 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.573 HD22 ' HB2' ' A' ' 12' ' ' SER . 7.2 p30 41.62 16.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.207 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' GLU . 43.2 t0 49.41 17.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.541 ' CD2' ' O ' ' A' ' 11' ' ' TRP . 87.5 t90 -140.26 10.77 2.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.573 ' HB2' HD22 ' A' ' 9' ' ' ASN . 1.1 m -163.03 162.05 25.73 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 1' ' ' GLY . 7.1 t -96.47 147.63 23.64 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.0 -123.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.589 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -82.05 -43.04 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.97 156.11 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.96 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' H ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -38.38 102.63 0.25 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.641 -0.219 . . . . 0.0 110.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -46.0 102.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.053 1.836 . . . . 0.0 112.396 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -179.83 23.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.792 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' ASN . 82.6 t90 48.52 106.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.113 0.482 . . . . 0.0 111.258 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 12' ' ' SER . . . -136.08 -92.14 0.34 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' SER . 80.6 m-85 -146.67 -35.76 0.25 Allowed 'General case' 0 N--CA 1.462 0.154 0 O-C-N 122.782 -0.246 . . . . 0.0 111.49 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -47.09 -105.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.092 0.472 . . . . 0.0 111.581 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 11' ' ' TRP . 52.2 p30 -75.17 29.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.816 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 92.1 m-20 56.33 -1.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.593 ' H ' ' C ' ' A' ' 9' ' ' ASN . 16.3 t90 -119.94 9.26 11.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.98 -173.66 1.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 1' ' ' GLY . 2.3 t -112.91 165.23 12.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -87.56 -169.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 110.488 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -60.05 -43.57 95.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 11.8 t -95.85 115.58 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.272 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 73.6 m . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.497 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.232 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' HE ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.75 151.34 39.89 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 117.082 0.441 . . . . 0.0 111.024 -178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.06 111.43 2.44 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.15 2.567 . . . . 0.0 112.363 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.548 HD21 ' HE ' ' A' ' 2' ' ' ARG . 4.9 p30 175.62 21.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.727 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.7 t90 41.63 69.69 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.958 0.409 . . . . 0.0 110.13 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -100.67 -85.87 1.89 Allowed Glycine 0 N--CA 1.463 0.449 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.948 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.75 -41.84 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.705 0.252 . . . . 0.0 111.409 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.599 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.0 pt-20 -67.53 148.37 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.508 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.584 HD22 ' HB2' ' A' ' 12' ' ' SER . 12.3 p30 40.07 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 50.83 22.84 1.24 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.721 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -144.02 7.16 1.39 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 110.401 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.584 ' HB2' HD22 ' A' ' 9' ' ' ASN . 2.3 m -159.36 166.42 31.17 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.918 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -104.55 154.02 20.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 111.057 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 15' ' ' ARG . 35.2 m -76.88 -54.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.645 ' N ' HG23 ' A' ' 14' ' ' VAL . 67.2 ttt180 -173.16 163.53 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 17' ' ' CYS . 92.0 t 55.45 -86.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' ARG . 12.0 m . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' ASN . 37.0 mtp85 -129.23 93.75 35.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.893 -0.181 . . . . 0.0 111.167 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.36 83.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.657 2.238 . . . . 0.0 112.915 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.541 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 3.6 t30 -172.69 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.748 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 10.0 m0 53.55 107.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.96 -130.34 1.18 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' SER . 78.2 m-85 -88.71 -65.62 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.577 ' OE1' ' ND2' ' A' ' 9' ' ' ASN . 2.5 pt-20 -48.66 147.66 2.46 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.435 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.664 HD22 ' HB2' ' A' ' 12' ' ' SER . 11.6 p30 41.82 17.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.922 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.4 t0 48.87 11.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.413 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' ASN . 83.6 m95 -133.57 15.31 4.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.664 ' HB2' HD22 ' A' ' 9' ' ' ASN . 3.9 m -162.23 162.2 28.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.388 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.51 155.05 18.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.785 0.326 . . . . 0.0 110.311 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 14' ' ' VAL . 15.5 m -94.38 -162.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.338 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -55.07 -43.48 73.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.688 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.3 108.46 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 110.465 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 36.5 t . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.435 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' HD22 ' A' ' 9' ' ' ASN . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -38.71 102.04 0.24 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.986 -0.107 . . . . 0.0 111.132 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.41 100.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.075 1.85 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' TRP . 45.4 t-20 -172.89 23.92 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.602 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.536 ' HE1' ' HE1' ' A' ' 11' ' ' TRP . 5.3 m-90 51.5 104.22 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -158.78 -148.85 5.32 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.21 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.1 -56.45 6.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -58.09 148.81 25.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.385 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.616 HD22 ' HB2' ' A' ' 12' ' ' SER . 8.2 p30 42.06 16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.9 m-20 47.06 22.85 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.536 ' HE1' ' HE1' ' A' ' 5' ' ' TRP . 82.6 t90 -144.5 10.38 1.43 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.668 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.616 ' HB2' HD22 ' A' ' 9' ' ' ASN . 4.3 m -162.73 162.96 27.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 2' ' ' ARG . 5.0 m -91.75 158.17 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.72 0.295 . . . . 0.0 111.02 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 m -78.75 -37.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.53 -72.06 0.32 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 m -122.25 131.42 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.143 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.488 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.262 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' H ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -174.94 104.09 0.26 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.956 0.378 . . . . 0.0 111.415 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.53 86.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.294 1.996 . . . . 0.0 112.658 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.6 m-20 -159.62 28.58 0.19 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 84.3 t90 47.63 91.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -143.13 -143.98 4.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.421 ' H ' ' HA ' ' A' ' 13' ' ' CYS . 96.9 m-85 -76.73 -57.83 3.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -54.64 143.59 24.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.224 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 11' ' ' TRP . 6.0 p30 41.8 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.638 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 8' ' ' GLU . 42.3 t0 54.46 -0.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.655 0.264 . . . . 0.0 110.96 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.586 ' H ' ' C ' ' A' ' 9' ' ' ASN . 3.3 m0 -112.88 0.4 15.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.803 0.335 . . . . 0.0 110.478 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.548 ' HB2' ' H ' ' A' ' 2' ' ' ARG . 4.2 p -159.29 166.81 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.222 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 10.6 t -99.22 163.39 12.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 32.8 m -90.97 -156.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -83.05 -47.63 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' CYS . 86.2 t -63.83 -46.79 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.349 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 14' ' ' VAL . 85.0 m . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.036 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.804 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.709 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -54.31 151.05 14.39 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.49 -178.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.98 99.85 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.674 2.249 . . . . 0.0 112.493 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.438 ' OD1' ' SG ' ' A' ' 13' ' ' CYS . 8.1 t-20 -174.98 -128.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.396 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.519 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 52.7 p-90 -161.48 99.72 1.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . . . -141.15 -156.83 6.95 Favored Glycine 0 N--CA 1.466 0.633 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.65 -38.5 89.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.006 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -70.29 145.03 51.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.53 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 11' ' ' TRP . 14.2 t-20 46.7 12.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 110.782 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' GLU . 6.0 p-10 43.07 19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.516 ' N ' ' O ' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.79 19.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.629 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' GLY . 3.6 m -147.13 150.15 34.41 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 110.258 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.438 ' SG ' ' OD1' ' A' ' 4' ' ' ASN . 1.1 m -63.51 151.71 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.27 -45.59 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.429 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -140.77 -84.87 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.973 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.19 9.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.495 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.702 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -132.08 92.4 29.46 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.26 85.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.305 2.003 . . . . 0.0 112.898 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.2 m-20 -160.55 32.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 54.26 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.587 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -155.28 -139.21 2.73 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.4 m-85 -80.35 -79.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -48.33 161.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.756 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.408 ' C ' ' N ' ' A' ' 11' ' ' TRP . 23.2 t-20 55.61 7.66 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 109.997 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 98.9 m-20 57.83 9.9 0.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.43 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 4.4 m-90 -160.16 29.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.587 ' N ' ' H ' ' A' ' 6' ' ' GLY . 67.1 m -153.29 147.88 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 14' ' ' VAL . 1.2 t -71.72 164.35 26.12 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -92.2 -165.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -55.45 -43.1 75.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 110.472 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.33 131.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.609 179.743 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.6 ptm85 -170.2 153.92 4.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.558 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.87 167.01 2.51 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.74 2.294 . . . . 0.0 112.142 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 37.1 t30 76.1 155.58 0.17 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.123 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 12.3 m0 -74.13 132.09 41.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -156.34 -137.21 2.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' SER . 94.7 m-85 -87.07 -83.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.679 0.276 . . . . 0.0 111.662 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.6 pt-20 -44.02 159.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.855 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' TRP . 24.2 t-20 53.88 12.2 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.129 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 68.8 m-20 57.57 7.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.114 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 5.0 m-90 -159.34 35.65 0.2 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.49 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 7' ' ' PHE . 38.7 m -158.52 140.78 14.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.1 m -68.87 158.31 34.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.032 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 16' ' ' VAL . 33.5 m -67.55 -143.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.397 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -59.32 -43.31 92.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 14' ' ' VAL . 2.4 t -131.13 124.87 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.315 179.721 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.508 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -82.35 156.36 68.8 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.847 0.356 . . . . 0.0 111.058 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 34.3 Cg_endo -62.07 169.68 7.28 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.604 2.203 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 83.36 114.4 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.209 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 42.2 p90 -37.82 120.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -148.07 -142.69 3.69 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.2 m-85 -80.82 -73.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -49.41 152.78 1.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.812 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 11' ' ' TRP . 22.9 t-20 54.24 8.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.214 0.531 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 55.75 5.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.942 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 9' ' ' ASN . 2.7 t-105 -142.66 21.23 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.17 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.1 t -154.35 153.53 31.77 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.312 0.577 . . . . 0.0 110.388 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.9 m -83.74 159.94 21.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.394 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 14' ' ' VAL . 2.4 m -80.4 -39.1 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -145.03 -65.07 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.37 131.3 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.627 -179.783 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.564 ' N ' HD22 ' A' ' 9' ' ' ASN . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' PRO . 16.0 mtp85 -82.45 141.39 45.49 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' ARG . 76.6 Cg_exo -41.12 172.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.721 2.281 . . . . 0.0 112.454 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' PRO . 76.9 m-20 58.3 121.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.816 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -41.15 135.31 1.88 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.88 -139.22 3.03 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -85.19 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 111.097 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' ASP . 7.2 pt-20 -50.32 145.93 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.7 HD22 ' HB2' ' A' ' 12' ' ' SER . 12.7 p30 40.98 17.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.284 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.3 t0 46.25 15.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.522 ' O ' ' CE3' ' A' ' 11' ' ' TRP . 69.2 t90 -135.83 12.28 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.7 ' HB2' HD22 ' A' ' 9' ' ' ASN . 2.5 m -164.22 166.23 21.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.259 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 8' ' ' GLU . 7.8 m -98.03 149.72 22.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.96 -23.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.037 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -167.68 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.84 133.99 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.769 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.704 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.673 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -72.79 154.36 91.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 0.0 110.702 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.29 -22.44 60.42 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.96 2.44 . . . . 0.0 112.519 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 5' ' ' TRP . 98.4 m-20 -68.7 118.97 12.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 4' ' ' ASN . 62.5 p-90 -32.89 141.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.598 0.561 . . . . 0.0 111.227 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.75 -135.37 2.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.292 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' SER . 89.9 m-85 -86.4 -62.49 1.5 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' C ' ' N ' ' A' ' 10' ' ' ASP . 4.2 pt-20 -50.98 162.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.227 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 11' ' ' TRP . 10.9 t-20 46.38 18.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.539 0.685 . . . . 0.0 110.144 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 8' ' ' GLU . 24.4 t0 51.45 11.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 11' ' ' TRP . 59.2 t-105 -159.45 37.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -167.48 151.04 6.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -81.05 158.98 24.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -98.28 -168.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.955 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -52.02 -44.32 64.12 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.314 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.65 122.94 56.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.468 -179.892 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.783 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.73 148.01 64.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 122.968 -0.136 . . . . 0.0 110.775 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 2' ' ' ARG . 50.8 Cg_exo -40.55 179.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.747 2.298 . . . . 0.0 112.468 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 4.4 m-20 79.2 98.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASN . 42.5 p-90 -35.53 121.94 0.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.21 -130.75 2.53 Favored Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -93.64 -68.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.551 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.7 pt-20 -46.26 145.08 1.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.704 HD22 ' HB2' ' A' ' 12' ' ' SER . 13.3 p30 41.31 18.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.867 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 45.84 13.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.946 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.513 ' N ' ' O ' ' A' ' 9' ' ' ASN . 78.6 m95 -133.53 11.11 4.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.727 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.704 ' HB2' HD22 ' A' ' 9' ' ' ASN . 3.7 m -159.95 162.76 34.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.911 0.386 . . . . 0.0 110.849 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.678 ' CB ' ' HE ' ' A' ' 2' ' ' ARG . 5.6 m -89.58 159.73 17.03 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 121.371 0.605 . . . . 0.0 111.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 15' ' ' ARG . 6.4 m -97.26 -118.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.456 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 14' ' ' VAL . 36.4 ttm180 -67.55 -55.9 11.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.302 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.97 164.92 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.432 179.496 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -89.61 159.1 44.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 2' ' ' ARG . 13.7 Cg_endo -54.2 -162.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.839 2.359 . . . . 0.0 112.085 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.41 113.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 66.6 p-90 -40.16 125.49 2.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.842 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -149.3 -136.71 2.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.3 m-85 -90.97 -70.8 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 10' ' ' ASP . 5.6 pt-20 -49.67 150.92 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.55 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.423 ' C ' ' H ' ' A' ' 11' ' ' TRP . 21.5 t-20 55.57 6.2 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.023 0.44 . . . . 0.0 110.315 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 8' ' ' GLU . 20.7 t70 63.09 2.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.353 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.423 ' H ' ' C ' ' A' ' 9' ' ' ASN . 5.7 t90 -146.86 26.85 1.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.708 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.9 m -153.97 147.27 24.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -80.36 165.75 21.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.102 -179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.39 -172.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.187 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.43 140.73 58.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.269 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 t 67.82 59.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.201 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.483 -179.609 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' H ' ' HB2' ' A' ' 12' ' ' SER . 4.5 ptm180 -173.36 154.4 2.53 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 26.3 Cg_endo -59.78 156.27 38.85 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.509 2.139 . . . . 0.0 112.228 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 90.13 110.21 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.329 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -40.53 114.53 0.47 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.566 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -138.43 -142.03 4.25 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' SER . 96.8 m-85 -80.69 -64.65 1.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.6 pt-20 -57.03 147.55 23.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.003 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' TRP . 17.4 t-20 56.33 5.22 0.17 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 8' ' ' GLU . 48.6 t0 62.19 -0.12 0.52 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -134.47 20.74 3.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.566 ' N ' ' H ' ' A' ' 6' ' ' GLY . 5.7 p -156.58 155.25 31.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 1.6 m -86.9 152.3 22.56 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -77.06 -92.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.814 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' H ' HG23 ' A' ' 14' ' ' VAL . 78.7 ttt-85 -131.21 -21.93 2.57 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 53.4 t -121.67 131.92 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 1.7 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.168 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.728 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.71 146.96 65.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.775 -0.25 . . . . 0.0 111.658 -178.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.75 110.46 0.97 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.685 2.257 . . . . 0.0 112.329 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 56.5 t-20 -173.72 17.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 42.37 56.72 3.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.004 0.431 . . . . 0.0 110.405 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -85.6 -91.85 0.85 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.674 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' SER . 90.0 m-85 -154.1 -19.25 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.579 ' OE1' ' ND2' ' A' ' 9' ' ' ASN . 1.4 pt-20 -59.1 -103.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.277 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.579 ' ND2' ' OE1' ' A' ' 8' ' ' GLU . 21.5 p30 -70.18 38.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 8' ' ' GLU . 5.8 p-10 43.79 21.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 110.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.459 ' N ' ' O ' ' A' ' 9' ' ' ASN . 76.8 t90 -152.06 8.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.707 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.5 m -158.13 176.22 12.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 1' ' ' GLY . 47.9 t -105.95 160.64 15.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.056 0.455 . . . . 0.0 110.9 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 14' ' ' VAL . 7.2 m -81.6 -174.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -59.26 -45.62 90.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.95 107.33 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.845 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.2 m . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.609 -179.534 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' NH2' ' O ' ' A' ' 15' ' ' ARG . 8.3 mtp180 -128.92 145.68 57.47 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.38 84.99 0.9 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.77 2.313 . . . . 0.0 112.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 64.0 t30 -174.41 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.269 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -175.64 102.53 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.804 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -138.44 -48.56 0.06 OUTLIER Glycine 0 N--CA 1.466 0.646 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.598 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 94.5 m-85 -159.68 -60.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.573 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -52.87 148.13 8.06 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.789 -177.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.405 ' O ' ' CG ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER 53.61 8.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.869 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 53.42 21.7 2.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' ASN . 0.0 OUTLIER -157.42 9.96 0.19 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.53 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.437 ' OG ' ' OE1' ' A' ' 8' ' ' GLU . 0.3 OUTLIER -142.12 161.16 38.7 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.27 147.15 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.874 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.94 151.77 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.49 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.497 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 15.4 tpp180 42.94 -129.26 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' O ' ' OXT' ' A' ' 17' ' ' CYS . 96.7 t -63.95 -46.29 94.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.819 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.503 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.537 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -111.2 146.65 34.98 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.853 0.327 . . . . 0.0 111.5 -178.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -71.26 86.96 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.677 2.252 . . . . 0.0 111.723 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' TRP . 82.2 m-20 -155.5 25.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' ASN . 88.4 t90 47.57 98.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -150.46 -141.94 3.46 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.263 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.0 m-85 -81.27 -54.22 5.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.4 pt-20 -68.19 151.92 46.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.65 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 11' ' ' TRP . 14.0 t-20 55.03 6.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.114 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLU . 99.0 m-20 57.88 2.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.541 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 t-105 -139.47 20.85 2.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 2' ' ' ARG . 11.2 t -153.8 158.62 41.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.414 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.96 155.59 16.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 15' ' ' ARG . 9.8 m -65.97 -44.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.09 0.472 . . . . 0.0 110.15 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 14' ' ' VAL . 26.5 tpt85 -157.48 -38.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.715 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.68 131.7 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.483 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.7 158.71 72.89 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.956 0.408 . . . . 0.0 110.782 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.88 -20.92 58.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.602 2.201 . . . . 0.0 111.526 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -64.59 -169.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 16.3 p90 -107.04 141.05 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.869 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.71 -123.36 0.77 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.2 m-85 -99.23 -67.56 0.84 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -53.84 176.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 11' ' ' TRP . 19.2 t-20 48.43 16.2 0.1 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' N ' ' C ' ' A' ' 8' ' ' GLU . 57.2 m-20 69.56 -10.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.052 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.541 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 p90 -166.43 73.14 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.529 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.51 ' N ' ' H ' ' A' ' 6' ' ' GLY . 18.8 m -171.28 144.87 2.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.16 159.05 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 29.1 m -81.87 -160.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.813 0.339 . . . . 0.0 110.473 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.26 130.38 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.453 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.583 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -101.83 103.94 32.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 122.592 -0.358 . . . . 0.0 110.883 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.06 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.091 1.861 . . . . 0.0 112.188 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -173.0 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.838 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 44.02 88.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.317 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -134.98 -125.4 2.53 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.3 m-85 -94.33 -66.2 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 10' ' ' ASP . 3.5 pt-20 -51.89 146.05 8.92 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.214 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.564 ' ND2' ' OG ' ' A' ' 12' ' ' SER . 7.9 p30 43.14 15.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.854 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.1 m-20 46.65 14.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.181 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.496 ' N ' ' O ' ' A' ' 9' ' ' ASN . 13.3 t-105 -126.71 2.73 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.969 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.564 ' OG ' ' ND2' ' A' ' 9' ' ' ASN . 10.2 p -159.7 165.53 32.4 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.984 0.421 . . . . 0.0 111.444 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.5 t -90.2 160.93 15.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.769 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -71.08 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' H ' HG23 ' A' ' 14' ' ' VAL . 42.0 ttp85 -139.32 119.67 13.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 15' ' ' ARG . 35.3 t 53.53 107.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.9 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.526 179.801 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -60.65 146.09 86.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 120.436 0.16 . . . . 0.0 111.011 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.12 25.46 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.897 2.398 . . . . 0.0 113.01 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' TRP . 87.4 m-20 -126.48 120.38 29.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 121.44 -0.104 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . 83.9 t90 -25.37 125.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.737 0.648 . . . . 0.0 111.742 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -166.78 -155.58 9.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.945 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -64.1 -48.91 74.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.9 pt-20 -63.8 149.01 47.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.658 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.573 HD22 ' HB2' ' A' ' 12' ' ' SER . 7.2 p30 41.62 16.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.207 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' GLU . 43.2 t0 49.41 17.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.541 ' CD2' ' O ' ' A' ' 11' ' ' TRP . 87.5 t90 -140.26 10.77 2.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.573 ' HB2' HD22 ' A' ' 9' ' ' ASN . 1.1 m -163.03 162.05 25.73 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 1' ' ' GLY . 7.1 t -96.47 147.63 23.64 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.0 -123.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.589 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -82.05 -43.04 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.97 156.11 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.96 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' H ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -38.38 102.63 0.25 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.641 -0.219 . . . . 0.0 110.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -46.0 102.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.053 1.836 . . . . 0.0 112.396 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -179.83 23.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.792 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' ASN . 82.6 t90 48.52 106.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.113 0.482 . . . . 0.0 111.258 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 12' ' ' SER . . . -136.08 -92.14 0.34 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' SER . 80.6 m-85 -146.67 -35.76 0.25 Allowed 'General case' 0 N--CA 1.462 0.154 0 O-C-N 122.782 -0.246 . . . . 0.0 111.49 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -47.09 -105.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.092 0.472 . . . . 0.0 111.581 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.593 ' C ' ' H ' ' A' ' 11' ' ' TRP . 52.2 p30 -75.17 29.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.816 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 92.1 m-20 56.33 -1.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.593 ' H ' ' C ' ' A' ' 9' ' ' ASN . 16.3 t90 -119.94 9.26 11.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.98 -173.66 1.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 1' ' ' GLY . 2.3 t -112.91 165.23 12.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -87.56 -169.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 110.488 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -60.05 -43.57 95.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 11.8 t -95.85 115.58 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.272 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 73.6 m . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.497 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.232 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.548 ' HE ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.75 151.34 39.89 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 117.082 0.441 . . . . 0.0 111.024 -178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.06 111.43 2.44 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.15 2.567 . . . . 0.0 112.363 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.548 HD21 ' HE ' ' A' ' 2' ' ' ARG . 4.9 p30 175.62 21.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.727 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.7 t90 41.63 69.69 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.958 0.409 . . . . 0.0 110.13 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -100.67 -85.87 1.89 Allowed Glycine 0 N--CA 1.463 0.449 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.948 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.75 -41.84 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.705 0.252 . . . . 0.0 111.409 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.599 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.0 pt-20 -67.53 148.37 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.508 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.708 HD22 ' N ' ' A' ' 11' ' ' TRP . 0.6 OUTLIER 40.07 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 50.83 22.84 1.24 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.721 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.708 ' N ' HD22 ' A' ' 9' ' ' ASN . 80.3 m95 -144.02 7.16 1.39 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 110.401 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.637 ' N ' HD21 ' A' ' 9' ' ' ASN . 2.3 m -159.36 166.42 31.17 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.918 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -104.55 154.02 20.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 111.057 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 15' ' ' ARG . 35.2 m -76.88 -54.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.645 ' N ' HG23 ' A' ' 14' ' ' VAL . 67.2 ttt180 -173.16 163.53 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 17' ' ' CYS . 92.0 t 55.45 -86.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' ARG . 12.0 m . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' ASN . 37.0 mtp85 -129.23 93.75 35.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.893 -0.181 . . . . 0.0 111.167 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.36 83.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.657 2.238 . . . . 0.0 112.915 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' ARG . 14.1 t-20 -172.69 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.748 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 10.0 m0 53.55 107.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.96 -130.34 1.18 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' SER . 78.2 m-85 -88.71 -65.62 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 2.5 pt-20 -48.66 147.66 2.46 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.435 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.821 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.82 17.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.922 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.4 t0 48.87 11.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.413 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.821 ' H ' HD22 ' A' ' 9' ' ' ASN . 83.6 m95 -133.57 15.31 4.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.636 ' N ' HD21 ' A' ' 9' ' ' ASN . 3.9 m -162.23 162.2 28.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.388 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.51 155.05 18.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.785 0.326 . . . . 0.0 110.311 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 14' ' ' VAL . 15.5 m -94.38 -162.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.338 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -55.07 -43.48 73.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.688 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.3 108.46 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 110.465 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 36.5 t . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.435 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -38.71 102.04 0.24 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.986 -0.107 . . . . 0.0 111.132 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.41 100.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.075 1.85 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' TRP . 45.4 t-20 -172.89 23.92 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.602 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.536 ' HE1' ' HE1' ' A' ' 11' ' ' TRP . 5.3 m-90 51.5 104.22 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -158.78 -148.85 5.32 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.21 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.1 -56.45 6.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -58.09 148.81 25.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.385 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.73 HD21 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 42.06 16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.9 m-20 47.06 22.85 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.706 ' N ' HD22 ' A' ' 9' ' ' ASN . 82.6 t90 -144.5 10.38 1.43 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.668 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.73 ' N ' HD21 ' A' ' 9' ' ' ASN . 4.3 m -162.73 162.96 27.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 2' ' ' ARG . 5.0 m -91.75 158.17 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.72 0.295 . . . . 0.0 111.02 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 m -78.75 -37.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.53 -72.06 0.32 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 m -122.25 131.42 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.143 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.488 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.262 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.548 ' H ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -174.94 104.09 0.26 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.956 0.378 . . . . 0.0 111.415 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.53 86.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.294 1.996 . . . . 0.0 112.658 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.6 m-20 -159.62 28.58 0.19 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 84.3 t90 47.63 91.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -143.13 -143.98 4.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.421 ' H ' ' HA ' ' A' ' 13' ' ' CYS . 96.9 m-85 -76.73 -57.83 3.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -54.64 143.59 24.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.224 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.892 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.8 OUTLIER 41.8 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.638 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 8' ' ' GLU . 42.3 t0 54.46 -0.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.655 0.264 . . . . 0.0 110.96 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.892 ' H ' HD22 ' A' ' 9' ' ' ASN . 3.3 m0 -112.88 0.4 15.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.803 0.335 . . . . 0.0 110.478 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.578 ' N ' HD21 ' A' ' 9' ' ' ASN . 4.2 p -159.29 166.81 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.222 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 10.6 t -99.22 163.39 12.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 32.8 m -90.97 -156.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -83.05 -47.63 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' CYS . 86.2 t -63.83 -46.79 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.349 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 14' ' ' VAL . 85.0 m . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.036 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.804 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.709 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -54.31 151.05 14.39 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.49 -178.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.98 99.85 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.674 2.249 . . . . 0.0 112.493 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 5' ' ' TRP . 14.7 t30 -174.98 -128.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.396 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.682 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 52.7 p-90 -161.48 99.72 1.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . . . -141.15 -156.83 6.95 Favored Glycine 0 N--CA 1.466 0.633 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.65 -38.5 89.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.006 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -70.29 145.03 51.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.53 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.54 ' ND2' ' CB ' ' A' ' 11' ' ' TRP . 5.4 t30 46.7 12.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 110.782 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' GLU . 6.0 p-10 43.07 19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.54 ' CB ' ' ND2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.79 19.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.629 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' GLY . 3.6 m -147.13 150.15 34.41 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 110.258 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' ' ND2' ' A' ' 4' ' ' ASN . 1.1 m -63.51 151.71 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.27 -45.59 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.429 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -140.77 -84.87 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.973 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.19 9.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.495 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.702 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -132.08 92.4 29.46 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.26 85.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.305 2.003 . . . . 0.0 112.898 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.2 m-20 -160.55 32.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 54.26 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.587 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -155.28 -139.21 2.73 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.4 m-85 -80.35 -79.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -48.33 161.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.756 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.408 ' C ' ' N ' ' A' ' 11' ' ' TRP . 25.9 t30 55.61 7.66 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 109.997 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 98.9 m-20 57.83 9.9 0.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.43 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 4.4 m-90 -160.16 29.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.587 ' N ' ' H ' ' A' ' 6' ' ' GLY . 67.1 m -153.29 147.88 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 14' ' ' VAL . 1.2 t -71.72 164.35 26.12 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -92.2 -165.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -55.45 -43.1 75.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 110.472 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.33 131.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.609 179.743 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.6 ptm85 -170.2 153.92 4.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.558 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.87 167.01 2.51 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.74 2.294 . . . . 0.0 112.142 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 37.1 t30 76.1 155.58 0.17 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.123 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 12.3 m0 -74.13 132.09 41.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -156.34 -137.21 2.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' SER . 94.7 m-85 -87.07 -83.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.679 0.276 . . . . 0.0 111.662 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.421 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.6 pt-20 -44.02 159.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.855 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' TRP . 20.4 t30 53.88 12.2 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.129 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 68.8 m-20 57.57 7.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.114 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 5.0 m-90 -159.34 35.65 0.2 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.49 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 7' ' ' PHE . 38.7 m -158.52 140.78 14.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.1 m -68.87 158.31 34.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.032 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 16' ' ' VAL . 33.5 m -67.55 -143.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.397 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -59.32 -43.31 92.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 14' ' ' VAL . 2.4 t -131.13 124.87 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.315 179.721 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.509 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.508 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -82.35 156.36 68.8 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.847 0.356 . . . . 0.0 111.058 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 34.3 Cg_endo -62.07 169.68 7.28 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.604 2.203 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 83.36 114.4 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.209 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 42.2 p90 -37.82 120.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -148.07 -142.69 3.69 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.2 m-85 -80.82 -73.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -49.41 152.78 1.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.812 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 11' ' ' TRP . 8.2 t30 54.24 8.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.214 0.531 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 55.75 5.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.942 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 9' ' ' ASN . 2.7 t-105 -142.66 21.23 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.17 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.1 t -154.35 153.53 31.77 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.312 0.577 . . . . 0.0 110.388 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.9 m -83.74 159.94 21.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.394 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 14' ' ' VAL . 2.4 m -80.4 -39.1 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -145.03 -65.07 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.37 131.3 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.627 -179.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' PRO . 16.0 mtp85 -82.45 141.39 45.49 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' ARG . 76.6 Cg_exo -41.12 172.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.721 2.281 . . . . 0.0 112.454 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' PRO . 76.9 m-20 58.3 121.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.816 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -41.15 135.31 1.88 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.88 -139.22 3.03 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -85.19 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 111.097 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' ASP . 7.2 pt-20 -50.32 145.93 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.785 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 40.98 17.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.284 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.3 t0 46.25 15.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.785 ' H ' HD22 ' A' ' 9' ' ' ASN . 69.2 t90 -135.83 12.28 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.728 ' N ' HD21 ' A' ' 9' ' ' ASN . 2.5 m -164.22 166.23 21.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.259 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 8' ' ' GLU . 7.8 m -98.03 149.72 22.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.96 -23.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.037 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -167.68 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.84 133.99 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.769 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.704 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.673 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -72.79 154.36 91.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 0.0 110.702 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.29 -22.44 60.42 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.96 2.44 . . . . 0.0 112.519 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 5' ' ' TRP . 98.4 m-20 -68.7 118.97 12.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 4' ' ' ASN . 62.5 p-90 -32.89 141.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.598 0.561 . . . . 0.0 111.227 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.75 -135.37 2.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.292 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' SER . 89.9 m-85 -86.4 -62.49 1.5 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.474 ' C ' ' N ' ' A' ' 10' ' ' ASP . 4.2 pt-20 -50.98 162.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.227 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 11' ' ' TRP . 12.8 t30 46.38 18.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.539 0.685 . . . . 0.0 110.144 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 8' ' ' GLU . 24.4 t0 51.45 11.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 11' ' ' TRP . 59.2 t-105 -159.45 37.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -167.48 151.04 6.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -81.05 158.98 24.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -98.28 -168.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.955 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -52.02 -44.32 64.12 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.314 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.65 122.94 56.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.468 -179.892 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.783 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.73 148.01 64.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 122.968 -0.136 . . . . 0.0 110.775 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 2' ' ' ARG . 50.8 Cg_exo -40.55 179.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.747 2.298 . . . . 0.0 112.468 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 4.4 m-20 79.2 98.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASN . 42.5 p-90 -35.53 121.94 0.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.21 -130.75 2.53 Favored Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -93.64 -68.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.56 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 6.7 pt-20 -46.26 145.08 1.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.83 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.31 18.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.867 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 45.84 13.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.946 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.83 ' H ' HD22 ' A' ' 9' ' ' ASN . 78.6 m95 -133.53 11.11 4.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.727 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.729 ' N ' HD21 ' A' ' 9' ' ' ASN . 3.7 m -159.95 162.76 34.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.911 0.386 . . . . 0.0 110.849 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.678 ' CB ' ' HE ' ' A' ' 2' ' ' ARG . 5.6 m -89.58 159.73 17.03 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 121.371 0.605 . . . . 0.0 111.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 15' ' ' ARG . 6.4 m -97.26 -118.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.456 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 14' ' ' VAL . 36.4 ttm180 -67.55 -55.9 11.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.302 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.97 164.92 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.432 179.496 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -89.61 159.1 44.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 2' ' ' ARG . 13.7 Cg_endo -54.2 -162.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.839 2.359 . . . . 0.0 112.085 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.41 113.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 66.6 p-90 -40.16 125.49 2.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.842 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.403 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -149.3 -136.71 2.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.3 m-85 -90.97 -70.8 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 10' ' ' ASP . 5.6 pt-20 -49.67 150.92 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.55 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 11' ' ' TRP . 9.9 t30 55.57 6.2 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.023 0.44 . . . . 0.0 110.315 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 8' ' ' GLU . 20.7 t70 63.09 2.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.353 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.424 ' HB3' ' ND2' ' A' ' 9' ' ' ASN . 5.7 t90 -146.86 26.85 1.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.708 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.9 m -153.97 147.27 24.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -80.36 165.75 21.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.102 -179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.39 -172.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.187 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.43 140.73 58.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.269 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 t 67.82 59.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.201 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.483 -179.609 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.492 ' H ' ' HB2' ' A' ' 12' ' ' SER . 4.5 ptm180 -173.36 154.4 2.53 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 26.3 Cg_endo -59.78 156.27 38.85 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.509 2.139 . . . . 0.0 112.228 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 90.13 110.21 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.329 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -40.53 114.53 0.47 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.566 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -138.43 -142.03 4.25 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' SER . 96.8 m-85 -80.69 -64.65 1.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.6 pt-20 -57.03 147.55 23.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.003 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' TRP . 5.8 t30 56.33 5.22 0.17 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 8' ' ' GLU . 48.6 t0 62.19 -0.12 0.52 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -134.47 20.74 3.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.566 ' N ' ' H ' ' A' ' 6' ' ' GLY . 5.7 p -156.58 155.25 31.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 1.6 m -86.9 152.3 22.56 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -77.06 -92.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.814 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' H ' HG23 ' A' ' 14' ' ' VAL . 78.7 ttt-85 -131.21 -21.93 2.57 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 53.4 t -121.67 131.92 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 1.7 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.168 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.728 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.71 146.96 65.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.775 -0.25 . . . . 0.0 111.658 -178.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.75 110.46 0.97 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.685 2.257 . . . . 0.0 112.329 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 56.5 t-20 -173.72 17.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 42.37 56.72 3.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.004 0.431 . . . . 0.0 110.405 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -85.6 -91.85 0.85 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.674 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' SER . 90.0 m-85 -154.1 -19.25 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 10' ' ' ASP . 1.4 pt-20 -59.1 -103.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.277 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.844 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -70.18 38.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 8' ' ' GLU . 5.8 p-10 43.79 21.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 110.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.844 ' H ' HD22 ' A' ' 9' ' ' ASN . 76.8 t90 -152.06 8.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.707 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' HD21 ' A' ' 9' ' ' ASN . 2.5 m -158.13 176.22 12.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 1' ' ' GLY . 47.9 t -105.95 160.64 15.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.056 0.455 . . . . 0.0 110.9 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 14' ' ' VAL . 7.2 m -81.6 -174.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -59.26 -45.62 90.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.95 107.33 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.845 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.2 m . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.609 -179.534 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.497 ' NH2' ' O ' ' A' ' 15' ' ' ARG . 8.3 mtp180 -128.92 145.68 57.47 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.38 84.99 0.9 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.77 2.313 . . . . 0.0 112.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 64.0 t30 -174.41 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.269 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -175.64 102.53 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.804 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -138.44 -48.56 0.06 OUTLIER Glycine 0 N--CA 1.466 0.646 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.598 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 94.5 m-85 -159.68 -60.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.573 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -52.87 148.13 8.06 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.789 -177.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.62 HD21 ' CB ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 53.61 8.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.869 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 53.42 21.7 2.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.62 ' CB ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -157.42 9.96 0.19 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.53 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -142.12 161.16 38.7 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.27 147.15 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.874 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.94 151.77 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.49 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.497 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 15.4 tpp180 42.94 -129.26 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.425 ' O ' ' OXT' ' A' ' 17' ' ' CYS . 96.7 t -63.95 -46.29 94.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.819 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.503 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.537 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -111.2 146.65 34.98 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.853 0.327 . . . . 0.0 111.5 -178.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 70.2 Cg_endo -71.26 86.96 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.677 2.252 . . . . 0.0 111.723 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 3' ' ' PRO . 17.7 m120 -155.5 25.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' ASN . 88.4 t90 47.57 98.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.498 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -150.46 -141.94 3.46 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.263 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.0 m-85 -81.27 -54.22 5.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.4 pt-20 -68.19 151.92 46.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.65 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 11' ' ' TRP . 4.8 t30 55.03 6.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.114 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLU . 99.0 m-20 57.88 2.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.541 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 t-105 -139.47 20.85 2.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 2' ' ' ARG . 11.2 t -153.8 158.62 41.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.414 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.96 155.59 16.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 15' ' ' ARG . 9.8 m -65.97 -44.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.09 0.472 . . . . 0.0 110.15 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 14' ' ' VAL . 26.5 tpt85 -157.48 -38.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.715 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.68 131.7 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.483 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.7 158.71 72.89 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.956 0.408 . . . . 0.0 110.782 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.88 -20.92 58.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.602 2.201 . . . . 0.0 111.526 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -64.59 -169.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 16.3 p90 -107.04 141.05 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.869 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.71 -123.36 0.77 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.2 m-85 -99.23 -67.56 0.84 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -53.84 176.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.668 ' ND2' ' CD1' ' A' ' 11' ' ' TRP . 34.6 t30 48.43 16.2 0.1 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.479 ' N ' ' C ' ' A' ' 8' ' ' GLU . 57.2 m-20 69.56 -10.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.052 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.668 ' CD1' ' ND2' ' A' ' 9' ' ' ASN . 1.2 p90 -166.43 73.14 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.529 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.51 ' N ' ' H ' ' A' ' 6' ' ' GLY . 18.8 m -171.28 144.87 2.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.16 159.05 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.412 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 29.1 m -81.87 -160.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.813 0.339 . . . . 0.0 110.473 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.26 130.38 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.453 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.583 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -101.83 103.94 32.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 122.592 -0.358 . . . . 0.0 110.883 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.06 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.091 1.861 . . . . 0.0 112.188 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -173.0 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.838 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 44.02 88.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.317 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -134.98 -125.4 2.53 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.3 m-85 -94.33 -66.2 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.559 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 3.5 pt-20 -51.89 146.05 8.92 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.214 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.785 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 43.14 15.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.854 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.1 m-20 46.65 14.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.181 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.785 ' H ' HD22 ' A' ' 9' ' ' ASN . 13.3 t-105 -126.71 2.73 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.969 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.598 ' N ' HD21 ' A' ' 9' ' ' ASN . 10.2 p -159.7 165.53 32.4 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.984 0.421 . . . . 0.0 111.444 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.5 t -90.2 160.93 15.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.769 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -71.08 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.49 ' H ' HG23 ' A' ' 14' ' ' VAL . 42.0 ttp85 -139.32 119.67 13.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 15' ' ' ARG . 35.3 t 53.53 107.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.9 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.526 179.801 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -60.65 146.09 86.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 120.436 0.16 . . . . 0.0 111.011 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.12 25.46 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.897 2.398 . . . . 0.0 113.01 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' TRP . 13.9 m120 -126.48 120.38 29.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 121.44 -0.104 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . 83.9 t90 -25.37 125.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.737 0.648 . . . . 0.0 111.742 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -166.78 -155.58 9.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.945 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -64.1 -48.91 74.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.569 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 5.9 pt-20 -63.8 149.01 47.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.658 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 41.62 16.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.207 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' GLU . 43.2 t0 49.41 17.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.706 ' H ' HD22 ' A' ' 9' ' ' ASN . 87.5 t90 -140.26 10.77 2.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.71 ' N ' HD21 ' A' ' 9' ' ' ASN . 1.1 m -163.03 162.05 25.73 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 1' ' ' GLY . 7.1 t -96.47 147.63 23.64 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.0 -123.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.589 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -82.05 -43.04 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.97 156.11 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.96 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HD2' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -38.38 102.63 0.25 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.641 -0.219 . . . . 0.0 110.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -46.0 102.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.053 1.836 . . . . 0.0 112.396 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -179.83 23.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.792 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' ASN . 82.6 t90 48.52 106.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.113 0.482 . . . . 0.0 111.258 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 12' ' ' SER . . . -136.08 -92.14 0.34 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' SER . 80.6 m-85 -146.67 -35.76 0.25 Allowed 'General case' 0 N--CA 1.462 0.154 0 O-C-N 122.782 -0.246 . . . . 0.0 111.49 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -47.09 -105.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.092 0.472 . . . . 0.0 111.581 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.84 ' ND2' ' H ' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -75.17 29.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.816 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 92.1 m-20 56.33 -1.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.84 ' H ' ' ND2' ' A' ' 9' ' ' ASN . 16.3 t90 -119.94 9.26 11.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.98 -173.66 1.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 1' ' ' GLY . 2.3 t -112.91 165.23 12.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -87.56 -169.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 110.488 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -60.05 -43.57 95.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 11.8 t -95.85 115.58 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.272 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 73.6 m . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.497 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.232 0 N-CA-C 112.196 -0.361 . . . . 0.0 112.196 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' HE ' HD21 ' A' ' 4' ' ' ASN . 0.0 OUTLIER -105.75 151.34 39.89 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 117.082 0.441 . . . . 0.0 111.024 -178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.06 111.43 2.44 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 C-N-CA 123.15 2.567 . . . . 0.0 112.363 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.548 HD21 ' HE ' ' A' ' 2' ' ' ARG . 4.9 p30 175.62 21.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.727 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 2.7 t90 41.63 69.69 0.33 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.958 0.409 . . . . 0.0 110.13 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -100.67 -85.87 1.89 Allowed Glycine 0 N--CA 1.463 0.449 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.948 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -136.75 -41.84 0.6 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.705 0.252 . . . . 0.0 111.409 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.599 ' O ' ' N ' ' A' ' 10' ' ' ASP . 5.0 pt-20 -67.53 148.37 51.57 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.508 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.708 HD22 ' N ' ' A' ' 11' ' ' TRP . 0.6 OUTLIER 40.07 15.35 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 179.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.599 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 50.83 22.84 1.24 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.721 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.708 ' N ' HD22 ' A' ' 9' ' ' ASN . 80.3 m95 -144.02 7.16 1.39 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.789 0.328 . . . . 0.0 110.401 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.637 ' N ' HD21 ' A' ' 9' ' ' ASN . 2.3 m -159.36 166.42 31.17 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.918 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.565 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.8 OUTLIER -104.55 154.02 20.45 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.001 0.429 . . . . 0.0 111.057 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.645 HG23 ' N ' ' A' ' 15' ' ' ARG . 35.2 m -76.88 -54.85 12.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.057 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.645 ' N ' HG23 ' A' ' 14' ' ' VAL . 67.2 ttt180 -173.16 163.53 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' O ' ' O ' ' A' ' 17' ' ' CYS . 92.0 t 55.45 -86.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.734 0.302 . . . . 0.0 110.474 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.453 ' N ' ' O ' ' A' ' 15' ' ' ARG . 12.0 m . . . . . 0 C--O 1.219 -0.53 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.623 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.971 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.5 ' O ' ' N ' ' A' ' 4' ' ' ASN . 37.0 mtp85 -129.23 93.75 35.3 Favored Pre-proline 0 CA--C 1.54 0.587 0 O-C-N 122.893 -0.181 . . . . 0.0 111.167 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -45.36 83.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.657 2.238 . . . . 0.0 112.915 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' ARG . 14.1 t-20 -172.69 34.01 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.748 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.502 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 10.0 m0 53.55 107.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.994 0.426 . . . . 0.0 111.041 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.96 -130.34 1.18 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.458 -0.657 . . . . 0.0 111.458 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 12' ' ' SER . 78.2 m-85 -88.71 -65.62 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.548 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 2.5 pt-20 -48.66 147.66 2.46 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.435 -178.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.821 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.82 17.59 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.922 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.4 t0 48.87 11.9 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.413 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.821 ' H ' HD22 ' A' ' 9' ' ' ASN . 83.6 m95 -133.57 15.31 4.04 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.76 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.636 ' N ' HD21 ' A' ' 9' ' ' ASN . 3.9 m -162.23 162.2 28.14 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.388 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -91.51 155.05 18.69 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.785 0.326 . . . . 0.0 110.311 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 14' ' ' VAL . 15.5 m -94.38 -162.6 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.338 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 63.7 ttm-85 -55.07 -43.48 73.92 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.688 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.3 108.46 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 120.808 0.337 . . . . 0.0 110.465 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.424 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 36.5 t . . . . . 0 C--O 1.221 -0.403 0 CA-C-O 118.083 -0.96 . . . . 0.0 110.435 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.568 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.432 ' CD ' ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -38.71 102.04 0.24 Allowed Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.986 -0.107 . . . . 0.0 111.132 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -45.41 100.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 122.075 1.85 . . . . 0.0 112.315 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.452 ' O ' ' O ' ' A' ' 5' ' ' TRP . 45.4 t-20 -172.89 23.92 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.602 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.536 ' HE1' ' HE1' ' A' ' 11' ' ' TRP . 5.3 m-90 51.5 104.22 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.525 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -158.78 -148.85 5.32 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.21 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -71.1 -56.45 6.1 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -58.09 148.81 25.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.029 -0.668 . . . . 0.0 110.385 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.73 HD21 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 42.06 16.06 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.125 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.9 m-20 47.06 22.85 0.23 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.706 ' N ' HD22 ' A' ' 9' ' ' ASN . 82.6 t90 -144.5 10.38 1.43 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.668 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.73 ' N ' HD21 ' A' ' 9' ' ' ASN . 4.3 m -162.73 162.96 27.01 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 177.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.432 ' O ' ' CD ' ' A' ' 2' ' ' ARG . 5.0 m -91.75 158.17 16.51 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.72 0.295 . . . . 0.0 111.02 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.6 m -78.75 -37.45 20.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.719 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -142.53 -72.06 0.32 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 10.6 m -122.25 131.42 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.143 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.22 -0.496 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.488 -179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.534 1.262 0 N-CA-C 112.111 -0.396 . . . . 0.0 112.111 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.548 ' H ' ' HB2' ' A' ' 12' ' ' SER . 0.0 OUTLIER -174.94 104.09 0.26 Allowed Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 116.956 0.378 . . . . 0.0 111.415 179.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -44.53 86.03 0.01 OUTLIER 'Trans proline' 0 N--CA 1.501 1.927 0 C-N-CA 122.294 1.996 . . . . 0.0 112.658 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.6 m-20 -159.62 28.58 0.19 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 84.3 t90 47.63 91.2 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.882 0.372 . . . . 0.0 110.795 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -143.13 -143.98 4.21 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.421 ' H ' ' HA ' ' A' ' 13' ' ' CYS . 96.9 m-85 -76.73 -57.83 3.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.583 ' O ' ' N ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -54.64 143.59 24.35 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.224 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.892 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.8 OUTLIER 41.8 13.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.638 179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.583 ' N ' ' O ' ' A' ' 8' ' ' GLU . 42.3 t0 54.46 -0.0 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.655 0.264 . . . . 0.0 110.96 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.892 ' H ' HD22 ' A' ' 9' ' ' ASN . 3.3 m0 -112.88 0.4 15.14 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.803 0.335 . . . . 0.0 110.478 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.578 ' N ' HD21 ' A' ' 9' ' ' ASN . 4.2 p -159.29 166.81 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.222 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 1' ' ' GLY . 10.6 t -99.22 163.39 12.57 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.041 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.535 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 32.8 m -90.97 -156.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.457 -179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -83.05 -47.63 11.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.842 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' CYS . 86.2 t -63.83 -46.79 93.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.349 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.535 ' SG ' ' O ' ' A' ' 14' ' ' VAL . 85.0 m . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.058 -0.972 . . . . 0.0 111.036 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.804 0 N-CA-C 112.297 -0.321 . . . . 0.0 112.297 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.709 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -54.31 151.05 14.39 Favored Pre-proline 0 CA--C 1.537 0.463 0 CA-C-O 120.685 0.278 . . . . 0.0 110.49 -178.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -64.98 99.85 0.34 Allowed 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 122.674 2.249 . . . . 0.0 112.493 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 5' ' ' TRP . 14.7 t30 -174.98 -128.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.396 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.682 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 52.7 p-90 -161.48 99.72 1.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.221 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 12' ' ' SER . . . -141.15 -156.83 6.95 Favored Glycine 0 N--CA 1.466 0.633 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.65 -38.5 89.52 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.62 -0.29 . . . . 0.0 111.006 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 10' ' ' ASP . 6.3 pt-20 -70.29 145.03 51.55 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 119.445 -0.902 . . . . 0.0 111.53 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.54 ' ND2' ' CB ' ' A' ' 11' ' ' TRP . 5.4 t30 46.7 12.53 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.083 0.468 . . . . 0.0 110.782 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.522 ' N ' ' O ' ' A' ' 8' ' ' GLU . 6.0 p-10 43.07 19.32 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.597 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.54 ' CB ' ' ND2' ' A' ' 9' ' ' ASN . 0.0 OUTLIER -154.79 19.15 0.45 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.629 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 6' ' ' GLY . 3.6 m -147.13 150.15 34.41 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.72 0.295 . . . . 0.0 110.258 178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.593 ' SG ' ' ND2' ' A' ' 4' ' ' ASN . 1.1 m -63.51 151.71 40.57 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.27 -45.59 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.429 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -140.77 -84.87 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.973 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -117.19 9.2 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.495 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 m . . . . . 0 C--O 1.22 -0.484 0 CA-C-O 118.037 -0.982 . . . . 0.0 110.702 179.816 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 N-CA-C 111.919 -0.473 . . . . 0.0 111.919 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.544 ' NE ' ' O ' ' A' ' 14' ' ' VAL . 0.7 OUTLIER -132.08 92.4 29.46 Favored Pre-proline 0 N--CA 1.468 0.435 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -45.26 85.96 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.305 2.003 . . . . 0.0 112.898 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 2' ' ' ARG . 80.2 m-20 -160.55 32.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.843 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 8.1 t-105 54.26 96.26 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.527 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.587 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -155.28 -139.21 2.73 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.4 m-85 -80.35 -79.82 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -48.33 161.57 0.11 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.756 -179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.408 ' C ' ' N ' ' A' ' 11' ' ' TRP . 25.9 t30 55.61 7.66 0.26 Allowed 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 109.997 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 98.9 m-20 57.83 9.9 0.99 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.43 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.513 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 4.4 m-90 -160.16 29.71 0.17 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.099 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.587 ' N ' ' H ' ' A' ' 6' ' ' GLY . 67.1 m -153.29 147.88 26.17 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 178.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 14' ' ' VAL . 1.2 t -71.72 164.35 26.12 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.597 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -92.2 -165.03 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -55.45 -43.1 75.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 110.472 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -133.33 131.41 57.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.657 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.7 p . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.609 179.743 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.458 ' O ' ' OG ' ' A' ' 12' ' ' SER . 2.6 ptm85 -170.2 153.92 4.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 C-N-CA 120.314 -0.554 . . . . 0.0 110.558 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.87 167.01 2.51 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 122.74 2.294 . . . . 0.0 112.142 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 37.1 t30 76.1 155.58 0.17 Allowed 'General case' 0 C--O 1.223 -0.308 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.123 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.504 ' N ' ' CD1' ' A' ' 5' ' ' TRP . 12.3 m0 -74.13 132.09 41.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.74 0.305 . . . . 0.0 110.491 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -156.34 -137.21 2.29 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.591 ' N ' ' O ' ' A' ' 12' ' ' SER . 94.7 m-85 -87.07 -83.74 0.19 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.679 0.276 . . . . 0.0 111.662 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.421 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.6 pt-20 -44.02 159.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.855 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' C ' ' H ' ' A' ' 11' ' ' TRP . 20.4 t30 53.88 12.2 0.41 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.113 0.482 . . . . 0.0 110.129 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.487 ' O ' ' CG ' ' A' ' 11' ' ' TRP . 68.8 m-20 57.57 7.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.114 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.487 ' CG ' ' O ' ' A' ' 10' ' ' ASP . 5.0 m-90 -159.34 35.65 0.2 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.49 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.591 ' O ' ' N ' ' A' ' 7' ' ' PHE . 38.7 m -158.52 140.78 14.11 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.435 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.1 m -68.87 158.31 34.78 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.032 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 16' ' ' VAL . 33.5 m -67.55 -143.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.397 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.9 mtp85 -59.32 -43.31 92.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.251 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.436 ' H ' HG23 ' A' ' 14' ' ' VAL . 2.4 t -131.13 124.87 56.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.315 179.721 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.534 1.27 0 N-CA-C 111.785 -0.526 . . . . 0.0 111.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.508 ' O ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -82.35 156.36 68.8 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 120.847 0.356 . . . . 0.0 111.058 -178.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 34.3 Cg_endo -62.07 169.68 7.28 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 122.604 2.203 . . . . 0.0 111.524 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.468 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 83.36 114.4 0.06 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.209 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.498 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 42.2 p90 -37.82 120.94 0.88 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.562 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -148.07 -142.69 3.69 Favored Glycine 0 CA--C 1.527 0.816 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' N ' ' O ' ' A' ' 12' ' ' SER . 84.2 m-85 -80.82 -73.73 0.35 Allowed 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.471 ' C ' ' H ' ' A' ' 10' ' ' ASP . 4.6 pt-20 -49.41 152.78 1.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.812 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 11' ' ' TRP . 8.2 t30 54.24 8.82 0.2 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.214 0.531 . . . . 0.0 110.124 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 55.75 5.09 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.942 -179.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.52 ' H ' ' C ' ' A' ' 9' ' ' ASN . 2.7 t-105 -142.66 21.23 2.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.17 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.1 t -154.35 153.53 31.77 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-O 121.312 0.577 . . . . 0.0 110.388 178.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.9 m -83.74 159.94 21.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.394 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG22 ' H ' ' A' ' 14' ' ' VAL . 2.4 m -80.4 -39.1 18.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -145.03 -65.07 0.33 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.663 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.37 131.3 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.8 m . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.627 -179.783 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.465 ' O ' ' O ' ' A' ' 3' ' ' PRO . 16.0 mtp85 -82.45 141.39 45.49 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.982 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.465 ' O ' ' O ' ' A' ' 2' ' ' ARG . 76.6 Cg_exo -41.12 172.7 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.721 2.281 . . . . 0.0 112.454 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 3' ' ' PRO . 76.9 m-20 58.3 121.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.816 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 70.4 p-90 -41.15 135.31 1.88 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.75 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.88 -139.22 3.03 Favored Glycine 0 N--CA 1.461 0.342 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -85.19 -62.07 1.62 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.702 0.287 . . . . 0.0 111.097 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.563 ' O ' ' N ' ' A' ' 10' ' ' ASP . 7.2 pt-20 -50.32 145.93 5.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.106 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.785 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 40.98 17.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.284 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 8' ' ' GLU . 45.3 t0 46.25 15.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.565 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.785 ' H ' HD22 ' A' ' 9' ' ' ASN . 69.2 t90 -135.83 12.28 3.4 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.342 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.728 ' N ' HD21 ' A' ' 9' ' ' ASN . 2.5 m -164.22 166.23 21.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.259 178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' O ' ' OE1' ' A' ' 8' ' ' GLU . 7.8 m -98.03 149.72 22.16 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.7 p -102.96 -23.08 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.037 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -167.68 -51.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.3 t -128.84 133.99 65.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.821 0.343 . . . . 0.0 110.769 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 13.4 p . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.704 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.673 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -72.79 154.36 91.16 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-O 120.702 0.287 . . . . 0.0 110.702 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.29 -22.44 60.42 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.96 2.44 . . . . 0.0 112.519 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 5' ' ' TRP . 98.4 m-20 -68.7 118.97 12.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.639 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.407 ' C ' ' O ' ' A' ' 4' ' ' ASN . 62.5 p-90 -32.89 141.06 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.598 0.561 . . . . 0.0 111.227 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.75 -135.37 2.16 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.292 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 12' ' ' SER . 89.9 m-85 -86.4 -62.49 1.5 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.474 ' C ' ' N ' ' A' ' 10' ' ' ASP . 4.2 pt-20 -50.98 162.11 0.31 Allowed 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.227 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 11' ' ' TRP . 12.8 t30 46.38 18.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.539 0.685 . . . . 0.0 110.144 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 8' ' ' GLU . 24.4 t0 51.45 11.65 0.13 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.778 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.486 ' O ' ' CD1' ' A' ' 11' ' ' TRP . 59.2 t-105 -159.45 37.6 0.2 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.5 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -167.48 151.04 6.32 Favored 'General case' 0 CA--C 1.536 0.404 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 177.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.568 ' O ' ' N ' ' A' ' 1' ' ' GLY . 0.1 OUTLIER -81.05 158.98 24.9 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 110.292 -0.262 . . . . 0.0 110.292 -179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.9 m -98.28 -168.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.955 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -52.02 -44.32 64.12 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.661 -0.415 . . . . 0.0 110.314 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.5 t -129.65 122.94 56.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 C--O 1.22 -0.463 0 CA-C-O 118.044 -0.979 . . . . 0.0 110.468 -179.892 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.609 -0.596 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.783 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -80.73 148.01 64.19 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 122.968 -0.136 . . . . 0.0 110.775 -178.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.583 ' O ' ' O ' ' A' ' 2' ' ' ARG . 50.8 Cg_exo -40.55 179.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.747 2.298 . . . . 0.0 112.468 179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.465 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 4.4 m-20 79.2 98.22 0.06 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.028 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASN . 42.5 p-90 -35.53 121.94 0.62 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.729 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.21 -130.75 2.53 Favored Glycine 0 CA--C 1.518 0.248 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -93.64 -68.08 0.82 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.985 0.421 . . . . 0.0 110.11 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.56 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 6.7 pt-20 -46.26 145.08 1.78 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.518 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.83 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 41.31 18.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.867 -179.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.8 m-20 45.84 13.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.946 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.83 ' H ' HD22 ' A' ' 9' ' ' ASN . 78.6 m95 -133.53 11.11 4.08 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.727 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.729 ' N ' HD21 ' A' ' 9' ' ' ASN . 3.7 m -159.95 162.76 34.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.911 0.386 . . . . 0.0 110.849 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.678 ' CB ' ' HE ' ' A' ' 2' ' ' ARG . 5.6 m -89.58 159.73 17.03 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-O 121.371 0.605 . . . . 0.0 111.23 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 15' ' ' ARG . 6.4 m -97.26 -118.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.456 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.405 ' N ' HG23 ' A' ' 14' ' ' VAL . 36.4 ttm180 -67.55 -55.9 11.63 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.991 0.424 . . . . 0.0 110.302 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.97 164.92 26.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.426 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.057 -0.973 . . . . 0.0 110.432 179.496 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.749 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.447 ' H ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -89.61 159.1 44.48 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 -179.58 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.41 ' O ' ' O ' ' A' ' 2' ' ' ARG . 13.7 Cg_endo -54.2 -162.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 122.839 2.359 . . . . 0.0 112.085 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 60.41 113.16 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.244 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.533 ' CD2' ' O ' ' A' ' 5' ' ' TRP . 66.6 p-90 -40.16 125.49 2.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.842 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.403 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -149.3 -136.71 2.68 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.3 m-85 -90.97 -70.8 0.66 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' A' ' 10' ' ' ASP . 5.6 pt-20 -49.67 150.92 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.959 -0.297 . . . . 0.0 110.55 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 11' ' ' TRP . 9.9 t30 55.57 6.2 0.17 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 121.023 0.44 . . . . 0.0 110.315 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 8' ' ' GLU . 20.7 t70 63.09 2.25 1.02 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.353 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.424 ' HB3' ' ND2' ' A' ' 9' ' ' ASN . 5.7 t90 -146.86 26.85 1.1 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.708 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 7' ' ' PHE . 2.9 m -153.97 147.27 24.84 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' O ' ' CD ' ' A' ' 8' ' ' GLU . 0.5 OUTLIER -80.36 165.75 21.96 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.896 0.379 . . . . 0.0 110.102 -179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.0 m -92.39 -172.36 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.187 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.43 140.73 58.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.269 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 t 67.82 59.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.201 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.5 t . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.483 -179.609 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' H ' ' HB2' ' A' ' 12' ' ' SER . 4.5 ptm180 -173.36 154.4 2.53 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.508 ' O ' ' CB ' ' A' ' 4' ' ' ASN . 26.3 Cg_endo -59.78 156.27 38.85 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.509 2.139 . . . . 0.0 112.228 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 3' ' ' PRO . 2.1 t-20 90.13 110.21 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.329 -179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -40.53 114.53 0.47 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.268 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.566 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -138.43 -142.03 4.25 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 111.555 -0.618 . . . . 0.0 111.555 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 12' ' ' SER . 96.8 m-85 -80.69 -64.65 1.14 Allowed 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.6 pt-20 -57.03 147.55 23.87 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.003 -178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 11' ' ' TRP . 5.8 t30 56.33 5.22 0.17 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.053 -179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 8' ' ' GLU . 48.6 t0 62.19 -0.12 0.52 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.857 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.502 ' H ' ' C ' ' A' ' 9' ' ' ASN . 0.1 OUTLIER -134.47 20.74 3.64 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.014 179.097 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.566 ' N ' ' H ' ' A' ' 6' ' ' GLY . 5.7 p -156.58 155.25 31.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.474 ' O ' ' CG ' ' A' ' 2' ' ' ARG . 1.6 m -86.9 152.3 22.56 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.052 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 15' ' ' ARG . 0.3 OUTLIER -77.06 -92.18 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.814 179.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' H ' HG23 ' A' ' 14' ' ' VAL . 78.7 ttt-85 -131.21 -21.93 2.57 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 53.4 t -121.67 131.92 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.868 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 1.7 m . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.982 -1.009 . . . . 0.0 110.168 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 112.277 -0.329 . . . . 0.0 112.277 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.728 ' H ' ' CD ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.71 146.96 65.96 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.775 -0.25 . . . . 0.0 111.658 -178.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -61.75 110.46 0.97 Allowed 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 122.685 2.257 . . . . 0.0 112.329 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 56.5 t-20 -173.72 17.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.453 179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 3.0 m-90 42.37 56.72 3.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.004 0.431 . . . . 0.0 110.405 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 12' ' ' SER . . . -85.6 -91.85 0.85 Allowed Glycine 0 CA--C 1.526 0.737 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.674 -179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 12' ' ' SER . 90.0 m-85 -154.1 -19.25 0.13 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' A' ' 10' ' ' ASP . 1.4 pt-20 -59.1 -103.09 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.277 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.844 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.4 OUTLIER -70.18 38.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.833 -179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 8' ' ' GLU . 5.8 p-10 43.79 21.72 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.021 0.438 . . . . 0.0 110.294 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.844 ' H ' HD22 ' A' ' 9' ' ' ASN . 76.8 t90 -152.06 8.44 0.48 Allowed 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.707 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.573 ' N ' HD21 ' A' ' 9' ' ' ASN . 2.5 m -158.13 176.22 12.79 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.126 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.582 ' O ' ' N ' ' A' ' 1' ' ' GLY . 47.9 t -105.95 160.64 15.12 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.056 0.455 . . . . 0.0 110.9 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 14' ' ' VAL . 7.2 m -81.6 -174.38 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.695 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 16.1 tpt180 -59.26 -45.62 90.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.097 -179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -101.95 107.33 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.845 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.2 m . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.609 -179.534 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.511 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.497 ' NH2' ' O ' ' A' ' 15' ' ' ARG . 8.3 mtp180 -128.92 145.68 57.47 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -71.38 84.99 0.9 Allowed 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.77 2.313 . . . . 0.0 112.17 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 11' ' ' TRP . 64.0 t30 -174.41 -121.15 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.269 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -175.64 102.53 0.08 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.804 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.546 ' O ' ' CG ' ' A' ' 7' ' ' PHE . . . -138.44 -48.56 0.06 OUTLIER Glycine 0 N--CA 1.466 0.646 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.598 179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CG ' ' O ' ' A' ' 6' ' ' GLY . 94.5 m-85 -159.68 -60.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.573 -179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 10' ' ' ASP . 0.8 OUTLIER -52.87 148.13 8.06 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 120.316 -0.554 . . . . 0.0 111.789 -177.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.62 HD21 ' CB ' ' A' ' 11' ' ' TRP . 0.0 OUTLIER 53.61 8.64 0.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.869 179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.488 ' H ' ' C ' ' A' ' 8' ' ' GLU . 98.7 m-20 53.42 21.7 2.52 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.334 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.62 ' CB ' HD21 ' A' ' 9' ' ' ASN . 0.0 OUTLIER -157.42 9.96 0.19 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.53 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.524 ' OG ' ' ND2' ' A' ' 9' ' ' ASN . 0.3 OUTLIER -142.12 161.16 38.7 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.27 147.15 27.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.874 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 6.0 p -122.94 151.77 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.866 0.365 . . . . 0.0 110.49 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.497 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 15.4 tpp180 42.94 -129.26 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.425 ' O ' ' OXT' ' A' ' 17' ' ' CYS . 96.7 t -63.95 -46.29 94.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.061 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--O 1.221 -0.399 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.819 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.503 ' N ' ' OG ' ' A' ' 12' ' ' SER . . . . . . . . 0 CA--C 1.529 0.953 0 N-CA-C 112.328 -0.309 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.537 ' N ' ' OG ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -111.2 146.65 34.98 Favored Pre-proline 0 CA--C 1.539 0.545 0 CA-C-N 116.853 0.327 . . . . 0.0 111.5 -178.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.532 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 70.2 Cg_endo -71.26 86.96 0.77 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.677 2.252 . . . . 0.0 111.723 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 3' ' ' PRO . 17.7 m120 -155.5 25.99 0.4 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' ASN . 88.4 t90 47.57 98.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.404 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.498 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -150.46 -141.94 3.46 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.263 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.0 m-85 -81.27 -54.22 5.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' A' ' 10' ' ' ASP . 2.4 pt-20 -68.19 151.92 46.25 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.65 -178.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 11' ' ' TRP . 4.8 t30 55.03 6.74 0.14 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.114 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' A' ' 8' ' ' GLU . 99.0 m-20 57.88 2.75 0.18 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.976 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.541 ' H ' ' C ' ' A' ' 9' ' ' ASN . 1.2 t-105 -139.47 20.85 2.55 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 2' ' ' ARG . 11.2 t -153.8 158.62 41.15 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.414 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.96 155.59 16.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG23 ' N ' ' A' ' 15' ' ' ARG . 9.8 m -65.97 -44.02 92.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.09 0.472 . . . . 0.0 110.15 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 14' ' ' VAL . 26.5 tpt85 -157.48 -38.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.715 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.7 t -125.68 131.7 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.798 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.501 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.761 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.483 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -79.7 158.71 72.89 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.956 0.408 . . . . 0.0 110.782 -179.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.88 -20.92 58.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.602 2.201 . . . . 0.0 111.526 178.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -64.59 -169.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.79 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.413 ' CD1' ' O ' ' A' ' 5' ' ' TRP . 16.3 p90 -107.04 141.05 38.87 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.869 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -176.71 -123.36 0.77 Allowed Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.494 ' N ' ' O ' ' A' ' 12' ' ' SER . 93.2 m-85 -99.23 -67.56 0.84 Allowed 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.479 ' C ' ' N ' ' A' ' 10' ' ' ASP . 3.2 pt-20 -53.84 176.34 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.809 0.338 . . . . 0.0 111.447 -178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.668 ' ND2' ' CD1' ' A' ' 11' ' ' TRP . 34.6 t30 48.43 16.2 0.1 Allowed 'General case' 0 CA--C 1.518 -0.269 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.479 ' N ' ' C ' ' A' ' 8' ' ' GLU . 57.2 m-20 69.56 -10.04 0.61 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.052 -177.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.668 ' CD1' ' ND2' ' A' ' 9' ' ' ASN . 1.2 p90 -166.43 73.14 0.15 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.529 178.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.51 ' N ' ' H ' ' A' ' 6' ' ' GLY . 18.8 m -171.28 144.87 2.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -55.16 159.05 2.69 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.412 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 29.1 m -81.87 -160.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.2 ttt-85 -60.29 -44.15 95.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.813 0.339 . . . . 0.0 110.473 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.26 130.38 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.453 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.3 t . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.583 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.13 0 N-CA-C 112.42 -0.272 . . . . 0.0 112.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 14' ' ' VAL . 0.0 OUTLIER -101.83 103.94 32.08 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 122.592 -0.358 . . . . 0.0 110.883 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -42.06 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.091 1.861 . . . . 0.0 112.188 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -173.0 31.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.838 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 57.9 t-105 44.02 88.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.317 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' H ' ' N ' ' A' ' 12' ' ' SER . . . -134.98 -125.4 2.53 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.504 ' N ' ' O ' ' A' ' 12' ' ' SER . 95.3 m-85 -94.33 -66.2 0.93 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.559 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 3.5 pt-20 -51.89 146.05 8.92 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.214 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.785 HD22 ' H ' ' A' ' 11' ' ' TRP . 0.7 OUTLIER 43.14 15.57 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.854 -179.696 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 8' ' ' GLU . 98.1 m-20 46.65 14.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.181 -179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.785 ' H ' HD22 ' A' ' 9' ' ' ASN . 13.3 t-105 -126.71 2.73 6.75 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.969 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.598 ' N ' HD21 ' A' ' 9' ' ' ASN . 10.2 p -159.7 165.53 32.4 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 120.984 0.421 . . . . 0.0 111.444 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.472 ' HA ' ' H ' ' A' ' 7' ' ' PHE . 1.5 t -90.2 160.93 15.96 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.769 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.521 ' O ' ' NH2' ' A' ' 2' ' ' ARG . 0.4 OUTLIER -71.08 -96.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.49 ' H ' HG23 ' A' ' 14' ' ' VAL . 42.0 ttp85 -139.32 119.67 13.83 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.422 ' O ' ' O ' ' A' ' 15' ' ' ARG . 35.3 t 53.53 107.88 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.839 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.9 p . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.526 179.801 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.528 0.857 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.3 mtp85 -60.65 146.09 86.48 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-O 120.436 0.16 . . . . 0.0 111.011 -179.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.12 25.46 0.19 Allowed 'Trans proline' 0 N--CA 1.5 1.859 0 C-N-CA 122.897 2.398 . . . . 0.0 113.01 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' TRP . 13.9 m120 -126.48 120.38 29.57 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 121.44 -0.104 . . . . 0.0 110.777 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' ASN . 83.9 t90 -25.37 125.37 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 O-C-N 123.737 0.648 . . . . 0.0 111.742 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' A' ' 12' ' ' SER . . . -166.78 -155.58 9.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.945 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -64.1 -48.91 74.31 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.569 ' O ' ' ND2' ' A' ' 9' ' ' ASN . 5.9 pt-20 -63.8 149.01 47.84 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.658 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER 41.62 16.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.207 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 8' ' ' GLU . 43.2 t0 49.41 17.57 0.22 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.706 ' H ' HD22 ' A' ' 9' ' ' ASN . 87.5 t90 -140.26 10.77 2.34 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.727 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.71 ' N ' HD21 ' A' ' 9' ' ' ASN . 1.1 m -163.03 162.05 25.73 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.516 ' O ' ' N ' ' A' ' 1' ' ' GLY . 7.1 t -96.47 147.63 23.64 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.861 0.362 . . . . 0.0 110.74 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.3 m -72.0 -123.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.589 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 96.2 mtt-85 -82.05 -43.04 18.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.75 0.309 . . . . 0.0 110.893 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.97 156.11 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.962 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.22 -0.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.96 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 13' ' ' CYS . . . . . . . . 0 CA--C 1.53 1.013 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.46 ' HD2' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -38.38 102.63 0.25 Allowed Pre-proline 0 CA--C 1.542 0.657 0 CA-C-O 119.641 -0.219 . . . . 0.0 110.974 179.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -46.0 102.35 0.04 OUTLIER 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 122.053 1.836 . . . . 0.0 112.396 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -179.83 23.61 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.792 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' ASN . 82.6 t90 48.52 106.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.113 0.482 . . . . 0.0 111.258 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 12' ' ' SER . . . -136.08 -92.14 0.34 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.568 ' N ' ' O ' ' A' ' 12' ' ' SER . 80.6 m-85 -146.67 -35.76 0.25 Allowed 'General case' 0 N--CA 1.462 0.154 0 O-C-N 122.782 -0.246 . . . . 0.0 111.49 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.512 ' CG ' ' H ' ' A' ' 9' ' ' ASN . 0.9 OUTLIER -47.09 -105.65 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.092 0.472 . . . . 0.0 111.581 -178.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.84 ' ND2' ' H ' ' A' ' 11' ' ' TRP . 0.1 OUTLIER -75.17 29.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.816 -179.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 8' ' ' GLU . 92.1 m-20 56.33 -1.06 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.608 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.84 ' H ' ' ND2' ' A' ' 9' ' ' ASN . 16.3 t90 -119.94 9.26 11.21 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.426 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.1 OUTLIER -169.98 -173.66 1.61 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.761 179.191 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' O ' ' N ' ' A' ' 1' ' ' GLY . 2.3 t -112.91 165.23 12.52 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.384 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -87.56 -169.45 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.778 0.323 . . . . 0.0 110.488 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -60.05 -43.57 95.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.669 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.498 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 11.8 t -95.85 115.58 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.272 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.498 ' SG ' ' O ' ' A' ' 16' ' ' VAL . 73.6 m . . . . . 0 C--O 1.221 -0.444 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.497 -179.712 . . . . . . . . 1 1 . 1 stop_ save_